Abstract
Objective:
Lumbar disc herniation (LDH) has demonstrated a rising prevalence in contemporary clinical practice, significantly compromising patients’ daily lives and potentially necessitating surgical intervention. While annulus fibrosus suture (AFS) techniques are increasingly incorporated into surgical protocols, current evidence remains inconclusive regarding their definitive clinical advantages.
Methods:
We performed a comprehensive search of eight databases from inception to September 2025 to identify published articles on AFS for LDH. Outcome measures encompassed operative time, incision length, blood loss, length of stay (LOS), visual analog scale (VAS) score, Japanese Orthopedic Association (JOA) score, Oswestry disability index (ODI) score, disc height, recurrence, and complication. The quality of the studies was analyzed using the RoB-2 and ROBINS-I tools. Statistical analyses were performed using RevMan 5.4 software and Stata 17 software. The GRADE approach was used to evaluate the certainty of evidence for outcomes.
Results:
A total of 58 studies encompassing 5,765 patients diagnosed with LDH. The control group had shorter operative time (MD = 4.85, 95% CI: 2.79 to 6.92, P < 0.00001) compared to the AFS group. There were no differences in terms of incision length, blood loss, LOS, JOA score, ODI score, and complication between the techniques. AFS group demonstrated a significant benefit over control group in terms of VAS score (MD = −0.24, 95% CI: −0.33 to −0.14, P < 0.00001), disc height (SMD = 1.36, 95% CI: 0.73 to 2.00, P < 0.0001), and recurrence (RR = 0.34, 95% CI: 0.27 to 0.42, P < 0.00001). The results of subgroup analysis showed that different study types and different follow-up times were a source of heterogeneity. The quality of evidence for outcome measures ranges from very low to moderate.
Conclusion:
Current evidence suggests that AFS therapy may be advantageous in improving clinical symptoms and may reduce postoperative recurrence. Due to limited data and low quality of evidence, additional large-scale, multicenter trials are needed to verify and strengthen these findings.
Introduction
Lumbar disc herniation (LDH) is a prevalent degenerative spinal disorder. LDH is caused by intervertebral disc degeneration, annulus fibrosus rupture, and nucleus pulposus tissue protrusion, which irritates the nerve root to cause clinical symptoms like lumbar back pain, motor, and sensory deficits (; ). LDH, which seriously affects patients’ daily lives and work, has a rising incidence due to socioeconomic development and lifestyle changes (; ). Moreover, the patient population is becoming younger, posing a heavy social burden (; ; ; ).
Currently, LDH treatment includes conservative and surgical approaches. Compared to conservative treatment, surgery more rapidly reduces pain, improves quality of life, and yields better patient satisfaction (; ; ). The key to surgical treatment is to accurately remove the herniated nucleus pulposus tissue to maximize the preservation of disc function and minimize annulus fibrosus damage. However, the annulus fibrosus, mainly composed of collagen fibers with limited self-repair ability, is often structurally compromised during surgery (; ). Its repair mainly relies on scar formation, resulting in low post-healing strength. The annulus incision or rupture site becomes a stress weak point. Residual nucleus pulposus in the intervertebral disc can easily re-herniate from here, causing LDH recurrence (; ). To lower this risk, surgeons often remove more of the surrounding nucleus pulposus. However, this accelerates intervertebral height loss and disc degeneration, which may destabilize the spinal structure. Studies identify the extent of annular injury as a key predictor of postoperative recurrence in lumbar disc herniation. Some studies also suggest that the degree of annular fibrosus injury is one of the key factors influencing postoperative recurrence (; ; ; ). Hence, it is crucial to preserve normal disc tissue and repair the damaged annulus fibrosus during surgery.
Current annulus fibrosus repair research focuses on two aspects, which are biological repair and physical repair (; ; ; ). Biological repair, using cell therapy, gene therapy, and biological materials, aims to maximally restore its physiological function (; ). Nevertheless, clinical application is limited due to inadequate mechanical strength, complex manufacturing processes, and poor biocompatibility (; ). Physical repair uses various methods to close the annulus fibrosus rupture to restore its structural integrity. Annular closure devices, now employed as implants, have demonstrated efficacy in reducing recurrence and reoperation rates (; ; ; ). However, there is still a need to consider the impact of associated financial costs, postoperative complications, and potential device loosening on patients (; ; ). Studies indicate that annulus fibrosus suture (AFS) can close ruptures directly, promote intervertebral disc structure restoration, maintain disc mechanical properties, and reduce scar formation (; ). However, some scholars argue that the AFS technique cannot provide sufficient mechanical strength to resist intradiscal pressure and annular fiber tension stress (; ). Therefore, this study aims to summarize the existing evidence and evaluate the efficacy and safety of AFS as an adjuvant treatment for LDH, offering more evidence-based medicine for clinical surgery.
Methods and materials
Protocol resister
This systematic review and meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (; ). Meanwhile, the protocol for this systematic review and meta-analysis was registered and published in the PROSPERO database on 2 May 2025 (registration number CRD420251078737).
Search strategy
Two reviewers conducted comprehensive searches on a total of eight electronic databases, including PubMed, Web of Science, EMBASE, Cochrane Library, Chinese National Knowledge Infrastructure, China Science and Technology Journal Database, Chinese WanFang Database, and Chinese Biomedical Literature Database. The searches cover the period from the inception date of the databases until 20 September 2025. No language or geographic restrictions were applied. In this study, a combination of Medical Subject Headings and free terms was searched, and the search terms were modified appropriately for different databases. Search strategies incorporated keywords such as “annulus fibrosus repair”, “annulus fibrosus”, “annulus fibrosus suture”, “lumbar disc herniation”, “lumbar disc protrusion”, “intervertebral disc displacement”, and “LDH”. Additionally, reference lists of the included articles, relevant reviews, and gray literature were examined to maximize research potential. Two reviewers assessed the eligibility of the articles based on their titles, abstracts, and keywords. The full search methods for each database are depicted in the Supplementary Material.
Eligibility criteria
Types of research: This study included all published randomized controlled trials (RCTs), cohort studies, and case-control studies.
Types of participant: The study included participants who were clearly diagnosed with LDH, without restrictions on age, gender, ethnicity, nationality, geographical location, or duration of disease.
Types of intervention: The treatment group received surgery combined with any type of AFS technique.
Types of comparison: The control group received surgery alone.
Outcome measures: The outcomes assessed were operative time, incision length, blood loss, length of stay (LOS), visual analog scale (VAS) score, Japanese Orthopedic Association (JOA) score, Oswestry disability index (ODI) score, disc height, recurrence, and complication.
Exclusion criteria
Literature contains overlapping data or multiple publications (defined as multiple publications reporting on the same patient from the same institution and time period; only the most comprehensive report was retained).
Reviews, conference papers, case reports, editor responses, animal experiments, basic experimental studies, technical notes, and review articles.
The data recorded in the literature are unknown (defined as essential numerical data for meta-analysis not provided, only presented in non-extractable graphical form, or described only qualitatively).
Literature screening and data extraction
Two reviewers assessed the eligibility of the articles based on their titles, abstracts, and keywords. The reviewer conducted an in-depth evaluation of the entire manuscript to make a final determination. Any disagreements were resolved by discussion and consensus. When necessary, the third reviewer made the final decision. Two independent reviewer authors used a systematic data extraction template to identify key study characteristics. Key study characteristics were identified using a systematic data extraction template, including details such as author details, year of publication, study design, sample size, sex ratio, patient mean age, body mass index, intervention, mean follow-up time, outcome indicators, and technical description of each treatment. Key outcomes were extracted by two other reviewers for data synthesis.
Risk of bias of individual studies
Two reviewers independently evaluated the methodological quality of the included literature. For RCTs, quality assessment was performed using the Cochrane Risk of Bias assessment tool, version 2 (RoB-2) (). Non-RCTs were evaluated using the Cochrane’s Risk of Bias In Non-Randomized Studies of Interventions (ROBINS-I) (). Disagreements between the authors were resolved in discussions. If no consensus could be reached, a third reviewer made the final decision.
Quality of evidence assessment
We utilized the principles of the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) system to evaluate the quality of evidence related to outcomes (; ). The system includes research design, heterogeneity, risk of bias, indirectness, imprecision, and publication bias. The rating of the study design was downgraded by one level if data from a mixed study design were used; the rating was not downgraded if data from RCTs were used. Two reviewers independently evaluated each domain for every outcome selected. In cases of disagreement, a third reviewer was consulted for resolution. All decisions regarding upgrading or downgrading the certainty of evidence were carefully documented to maintain transparency.
Statistical analysis
Statistical analysis was conducted using RevMan 5.4 software (Cochrane Collaboration, Oxford, UK) and Stata 17 software (StataCorp, College Station, USA). The risk ratio (RR) was utilized for comparing binary data, while the mean difference (MD) or standardized mean difference (SMD) was used for continuous data comparisons. The heterogeneity of articles was assessed using the chi-square test and I2 statistics. The I2 value of less than 50% indicated that there was no significant heterogeneity, and therefore, meta-analyses were conducted using a fixed-effects model. Conversely, a random effects model was used for the meta-analysis. If I2 exceeded 50%, a subgroup analysis was conducted based on the study design and length of follow-up to identify the source of heterogeneity. A sensitivity analysis was conducted by systematically excluding one study at a time to evaluate the robustness of the results. In addition, we conducted sensitivity analyses for adolescent populations and high-risk studies. Publication bias was evaluated through the funnel plot test and Egger’s test.
Results
Search selection
A preliminary search of eight databases yielded an initial collection of 10,789 articles on AFS as an adjuvant therapy for LDH. After removing 8,945 duplicate records, 721 articles were excluded after skimming through the title and abstract. Furthermore, 1,065 articles were eliminated after a thorough review of the full texts against the inclusion and exclusion criteria. Consequently, a total of 58 published articles (; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ) were included in this meta-analysis (Figure 1).
FIGURE 1
Baseline characteristics
A total of 5,765 participants with LDH were included in the 58 studies (; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ). There were 2,990 participants in the control group and 2,775 participants in the treatment group. All clinical trials were conducted from 2013 to 2025. The patients’ average age in the control group ranged from 14.63 to 69.81, while the average age of the treatment group ranged from 14.41 to 69.86. The follow-up period for the patients enrolled in these studies ranged from 6 months to 4.21 years. All studies had clear inclusion and exclusion criteria, with no significant baseline differences between the control and treatment groups. Among the 58 studies, forty-six investigated the effects of operative time (; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ), thirteen examined the effects of incision length (; ; ; ; ; ; ; ; ; ; ; ; ), forty-one specifically explored the effects of blood loss (; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ), twenty-three reported LOS (; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ), forty-seven trials focused on the impact of VAS score (; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ), twelve investigated the effects of JOA score (; ; ; ; ; ; ; ; ; ; ; ), forty-four examined the effects of ODI score (; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ), eleven explored the effects of disc height (; ; ; ; ; ; ; ; ; ; ), forty-eight specifically examined the effects of recurrence (; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ), and nine focused on the impact of complication (; ; ; ; ; ; ; ; ). Tables 1–3 summarize the characteristics of the included studies.
TABLE 1
| Inclusion studies | Study design | Sample size (Male/Female) | Patient age (years) | BMI (kg/m2) | Disease duration (months) |
|---|---|---|---|---|---|
| Cohort study | T: 26 (18/8) C: 32 (22/10) | T: 45 ± 12 C: 46 ± 10 | T: NA C: NA | T: NA C: NA | |
| RCT | T: 37 (22/15) C: 37 (21/16) | T: 15.51 ± 3.02 C: 15.26 ± 3.08 | T: NA C: NA | T: 11.36 ± 2.11 Month C: 11.26 ± 2.04 Month | |
| Cohort study | T: 22 (14/8) C: 34 (22/12) | T: 41.8 ± 10.6 C: 43.4 ± 9.8 | T: 23.1 ± 2.8 C: 22.7 ± 2.6 | T: 13.4 ± 2.4 Month C: 13.0 ± 2.6 Month | |
| Cohort study | T: 39 (13/26) C: 138 (69/69) | T: 57.98 ± 13.65 C: 59.26 ± 12.16 | T: 24.21 ± 3.26 C: 24.53 ± 3.20 | T: NA C: NA | |
| Cohort study | T: 35 (21/14) C: 31 (20/11) | T: 51.48 ± 9.33 C: 47.94 ± 8.81 | T: NA C: NA | T: 12.45 ± 2.13 Month C: 11.58 ± 2.67 Month | |
| Cohort study | T: 44 (26/18) C: 42 (25/17) | T: 38.8 ± 5.2 C: 37.9 ± 4.6 | T: 26.38 ± 4.21 C: 26.18 ± 4.59 | T: NA C: NA | |
| Cohort study | T: 212 (NA) C: 208 (NA) | 39.9 ± 5.1 | T: NA C: NA | T: NA C: NA | |
| RCT | T: 40 (29/11) C: 40 (28/12) | T: 69.86 ± 3.38 C: 69.81 ± 3.57 | T: 21.55 ± 3.06 C: 21.68 ± 3.12 | T: NA C: NA | |
| Cohort study | T: 25 (13/12) C: 25 (14/11) | T: 65.16 ± 2.32 C: 64.27 ± 2.41 | T: NA C: NA | T: NA C: NA | |
| Cohort study | T: 35 (19/16) C: 47 (25/22) | T: 48.32 ± 6.92 C: 47.65 ± 6.00 | T: NA C: NA | T: NA C: NA | |
| Cohort study | T: 31 (15/16) C: 41 (28/13) | T: 35.7 ± 7.2 C: 36.0 ± 12.2 | T: 22.5 ± 1.9 C: 22.9 ± 1.8 | T: 13.1 ± 5.5 Month C: 14.7 ± 5.6 Month | |
| Cohort study | T: 58 (29/29) C: 59 (33/26) | T: 49.31 ± 5.47 C: 48.25 ± 5.36 | T: 22.42 ± 1.24 C: 22.74 ± 1.26 | T: 16.85 ± 3.37 Month C: 17.56 ± 3.51 Month | |
| Cohort study | T: 60 (34/26) C: 67 (41/26) | T: 25.3 ± 2.9 C: 24.4 ± 3.5 | T: 24.6 ± 3.3 C: 24.3 ± 3.1 | T: NA C: NA | |
| Cohort study | T: 33 (15/18) C: 73 (31/42) | T: 47.81 ± 11.61 C: 52.81 ± 9.45 | T: 22.91 ± 3.61 C: 23.66 ± 2.79 | T: NA C: NA | |
| Cohort study | T: 42 (22/20) C: 41 (18/23) | T: 44.62 ± 7.02 C: 45.83 ± 7.31 | T: NA C: NA | T: 10.21 ± 5.15 Month C: 10.31 ± 5.56 Month | |
| Cohort study | T: 46 (26/20) C: 50 (22/28) | T: 36.78 ± 7.01 C: 34.56 ± 7.04 | T: NA C: NA | T: NA C: NA | |
| Cohort study | T: 27 (15/12) C: 32 (18/14) | T: NA C: NA | T: NA C: NA | T: NA C: NA | |
| Cohort study | T: 35 (19/16) C: 47 (25/22) | T: 48.3 ± 6.9 C: 47.7 ± 6.0 | T: 22.5 ± 1.1 C: 22.6 ± 1.3 | T: 8.1 ± 2.0 Month C: 7.7 ± 2.5 Month | |
| Cohort study | T: 30 (23/7) C: 30 (22/8) | T: 46.2 ± 6.64 C: 45.83 ± 8.24 | T: 22.64 ± 3.15 C: 23.17 ± 2.96 | T: NA C: NA | |
| RCT | T: 40 (22/18) C: 40 (21/19) | T: 60.3 ± 15.2 C: 61.5 ± 15.5 | T: NA C: NA | T: 22.2 ± 2.4 Month C: 22.4 ± 2.1 Month | |
| Cohort study | T: 37 (21/16) C: 30 (18/12) | T: 14.41 ± 1.89 C: 14.63 ± 1.95 | T: NA C: NA | T: 10.05 ± 2.57 Month C: 10.36 ± 2.74 Month | |
| Cohort study | T: 38 (25/13) C: 45 (24/21) | T: 39.05 ± 14.11 C: 43.13 ± 16.62 | T: NA C: NA | T: 13.76 ± 5.68 Month C: 14.93 ± 5.73 Month | |
| Cohort study | T: 32 (20/12) C: 36 (23/13) | T: 45.87 ± 6.11 C: 44.98 ± 6.31 | T: NA C: NA | T: NA C: NA | |
| Cohort study | T: 40 (22/18) C: 42 (23/19) | T: NA C: NA | T: NA C: NA | T: NA C: NA | |
| Cohort study | T: 32 (18/14) C: 33 (18/15) | T: 43 ± 6.8 C: 46 ± 9.3 | T: NA C: NA | T: NA C: NA | |
| Cohort study | T: 35 (19/16) C: 47 (25/22) | T: 36.2 ± 13.2 C: 38.2 ± 13.6 | T: NA C: NA | T: NA C: NA | |
| Cohort study | T: 39 (21/18) C: 47 (26/21) | T: 15.3 ± 1.9 C: 16.9 ± 0.8 | T: NA C: NA | T: NA C: NA | |
| RCT | T: 25 (NA) C: 25 (NA) | T: NA C: NA | T: NA C: NA | T: NA C: NA | |
| RCT | T: 100 (54/46) C: 100 (56/44) | T: 46.46 ± 8.74 C: 46.23 ± 8.48 | T: NA C: NA | T: 4.34 ± 0.98 Month C: 4.37 ± 0.92 Month | |
| Cohort study | T: 10 (7/3) C: 12 (8/4) | T: 19.3 ± 1.5 C: 19.2 ± 1.5 | T: NA C: NA | T: NA C: NA | |
| RCT | T: 60 (29/31) C: 60 (32/28) | T: 47.31 ± 10.52 C: 46.52 ± 10.38 | T: NA C: NA | T: NA C: NA | |
| Cohort study | T: 31 (18/13) C: 25 (16/9) | T: 29.45 ± 7.14 C: 27.78 ± 5.47 | T: 22.08 ± 1.69 C: 21.77 ± 1.54 | T: 10.40 ± 2.49 Month C: 11.13 ± 2.36 Month | |
| Cohort study | T: 51 (NA) C: 54 (NA) | T: 42.0 ± 11.6 C: 45.6 ± 12.2 | T: NA C: NA | T: 17.9 ± 4.1 Week C: 19.6 ± 4.7 Week | |
| Cohort study | T: 35 (23/12) C: 41 (26/15) | T: 42.39 ± 10.66 C: 37.5 ± 12.7 | T: NA C: NA | T: NA C: NA | |
| Cohort study | T: 20 (NA) C: 20 (NA) | T: NA C: NA | T: NA C: NA | T: NA C: NA | |
| Case-control study | T: 42 (25/17) C: 55 (31/24) | T: 42.3 ± 9.7 C: 41.8 ± 7.6 | T: NA C: NA | T: 3.2 ± 0.5 Year C: 3.4 ± 0.6 Year | |
| Cohort study | T: 22 (18/4) C: 28 (22/6) | T: 38 ± 17 C: 42 ± 10 | T: NA C: NA | T: NA C: NA | |
| Cohort study | T: 39 (22/17) C: 44 (26/18) | T: 42.6 ± 9.3 C: 44.1 ± 7.5 | T: NA C: NA | T: 37.2 ± 6.5 Month C: 35.8 ± 4.6 Month | |
| RCT | T: 21 (12/9) C: 24 (13/11) | T: 35 ± 10 C: 34 ± 11 | T: NA C: NA | T: NA C: NA | |
| Cohort study | T: 39 (22/17) C: 37 (23/14) | T: 42.5 ± 8.6 C: 43.7 ± 9.1 | T: NA C: NA | T: NA C: NA | |
| RCT | T: 60 (35/25) C: 60 (31/29) | T: 50.9 ± 7.2 C: 51.3 ± 7.2 | T: NA C: NA | T: 2.9 ± 0.4 Year C: 3.0 ± 0.4 Year | |
| Cohort study | T: 20 (12/8) C: 16 (9/7) | T: 16.9 ± 1.2 C: 17.4 ± 1.5 | T: NA C: NA | T: NA C: NA | |
| Cohort study | T: 33 (20/13) C: 33 (19/14) | T: 46.19 ± 6.35 C: 47.28 ± 7.41 | T: NA C: NA | T: 3.83 ± 1.17 Year C: 3.67 ± 1.05 Year | |
| Cohort study | T: 28 (17/11) C: 31 (19/12) | T: 49.52 ± 4.38 C: 49.48 ± 4.35 | T: NA C: NA | T: 3.2 ± 0.7 Month C: 3.2 ± 0.8 Month | |
| RCT | T: 25 (12/13) C: 23 (11/12) | T: 48.68 ± 6.00 C: 49.91 ± 7.01 | T: NA C: NA | T: NA C: NA | |
| Cohort study | T: 32 (19/13) C: 32 (20/12) | T: 39.03 ± 11.36 C: 38.96 ± 11.03 | T: NA C: NA | T: 5.71 ± 2.68 Year C: 5.59 ± 2.58 Year | |
| RCT | T: 34 (23/11) C: 34 (21/13) | T: 45.28 ± 2.94 C: 46.25 ± 3.27 | T: NA C: NA | T: 2.69 ± 0.82 Year C: 2.36 ± 0.67 Year | |
| Cohort study | T: 30 (13/17) C: 30 (14/16) | T: 39.8 ± 11.1 C: 40.3 ± 10.2 | T: NA C: NA | T: NA C: NA | |
| RCT | T: 28 (17/11) C: 28 (19/9) | T: 46.1 ± 11.4 C: 44.9 ± 12.5 | T: NA C: NA | T: 4.3 ± 0.9 Month C: 4.1 ± 1.2 Month | |
| Cohort study | T: 39 (21/18) C: 47 (24/23) | T: 14.3 ± 1.5 C: 15.1 ± 1.8 | T: NA C: NA | T: NA C: NA | |
| RCT | T: 36 (19/17) C: 33 (19/14) | T: 45.2 ± 4.7 C: 43.8 ± 5.1 | T: NA C: NA | T: NA C: NA | |
| Cohort study | T: 46 (NA) C: 46 (NA) | 51.7 ± 8.2 | T: NA C: NA | 13.9 ± 1.8 Month | |
| Cohort study | T: 118 (63/55) C: 172 (97/75) | T: 35.9 ± 11.6 C: 39.1 ± 12.2 | T: NA C: NA | T: NA C: NA | |
| Cohort study | T: 12 (7/5) C: 14 (9/5) | T: 17.9 ± 1.3 C: 18.2 ± 1.8 | T: NA C: NA | T: NA C: NA | |
| Cohort study | T: 18 (14/4) C: 20 (12/8) | T: 28.2 ± 6.4 C: 26.9 ± 6.1 | T: NA C: NA | T: 9.9 ± 3.9 Month C: 10 ± 2.8 Month | |
| RCT | T: 51 (30/21) C: 168 (92/76) | T: 38.8 ± 11.7 C: 37.7 ± 12.4 | T: NA C: NA | T: NA C: NA | |
| RCT | T: 478 (284/194) C: 249 (140/109) | T: 42.4 ± 11.3 C: 41.9 ± 11.6 | T: 28.6 ± 5.3 C: 29.1 ± 6.2 | T: 513 ± 1,101 Day C: 487 ± 1,119 Day | |
| Cohort study | T: 22 (17/5) C: 35 (23/12) | T: NA C: NA | T: NA C: NA | T: NA C: NA |
Basic characteristics of the fifty-eight studies included in the meta-analysis.
C, control group; NA, not available; RCT, randomized controlled trial; T, treatment group.
TABLE 2
| Inclusion studies | Treatment group | Control group | Suture equipment | Responsible levels | Outcomes | Follow-up |
|---|---|---|---|---|---|---|
| AFS + PTED | PTED | Disposable Suture Device | T: L4/L5 = 12, L5/S1 = 14 C: L3/L4 = 1 L4/L5 = 14, L5/S1 = 17 | Operative time Blood loss VAS score ODI score Recurrence | 15.7 Month | |
| AFS + PTED | PTED | Disposable Suture Device (EFIT-Ⅱ) | T: L3/L4 = 14, L4/L5 = 16, L5/S1 = 6 C: L3/L4 = 15, L4/L5 = 13, L5/S1 = 9 | Operative time Incision length Blood loss Recurrence | 12 Month | |
| AFS + PEID | TELD | Disposable Suture Device | T: L3/L4 = 5, L4/L5 = 9, L5/S1 = 8 C: L3/L4 = 8, L4/L5 = 14, L5/S1 = 12 | Operative time Incision length Blood loss LOS VAS score ODI score Recurrence | 14.3 ± 0.2 Month | |
| AFS + MED | MED | Disposable Suture Device | NA | Operative time Blood loss LOS VAS score JOA score Recurrence Complication | T: 26.46 ± 2.01 Month C: 26.83 ± 2.68 Month | |
| AFS + PELD | PELD | Disposable Suture Device | T: L3/L4 = 9, L4/L5 = 20, L5/S1 = 6 C: L3/L4 = 8, L4/L5 = 17, L5/S1 = 6 | Operative time Blood loss VAS score ODI score Recurrence | 12–15 Month | |
| AFS + PELD | PELD | Disposable Suture Device (STAR-S) | T: L3/L4 = 3, L4/L5 = 22, L5/S1 = 19 C: L3/L4 = 2, L4/L5 = 21, L5/S1 = 19 | Operative time LOS VAS score ODI score Recurrence | 12 Month | |
| AFS + PELD | PELD | NA | NA | Operative time Blood loss VAS score JOA score ODI score Recurrence | 15.2 ± 1.6 Month | |
| AFS + PTED | PTED | Disposable Suture Device | T: L4/L5 = 21, L5/S1 = 10, other = 9 C: L4/L5 = 20, L5/S1 = 11, other = 9 | Operative time Incision length Blood loss LOS VAS score JOA score ODI score Recurrence | 12 Month | |
| AFS + AUSS | AUSS | Disposable Suture Device | NA | LOS VAS score ODI score Recurrence Complication | NA | |
| AFS + PELD | PELD | Disposable Suture Device | T: L4/L5 = 20, L5/S1 = 15 C: L4/L5 = 27, L5/S1 = 20 | VAS score ODI score Recurrence | 18 Month | |
| AFS + TELD | TELD | Disposable Suture Device | T: L4/L5 = 11, L5/S1 = 20 C: L4/L5 = 16, L5/S1 = 25 | Operative time Blood loss LOS VAS score ODI score Recurrence | 12–24 Month | |
| AFS + PTED | PTED | Disposable Suture Device | T: L4/L5 = 34, L5/S1 = 24 C: L4/L5 = 30, L5/S1 = 29 | Operative time Incision length Blood loss LOS VAS score JOA score ODI score Disc height Recurrence Complication | 12 Month | |
| AFS + PEID | PEID | Disposable Suture Device | T: L4/L5 = 37, L5/S1 = 23 C: L4/L5 = 42, L5/S1 = 25 | Operative time VAS score ODI score | 12 Month | |
| AFS + PELD | PELD | Disposable Suture Device | T: L3/L4 = 10, L4/L5 = 13, L5/S1 = 10 C: L3/L4 = 17, L4/L5 = 35, L5/S1 = 21 | Operative time VAS score ODI score Disc height Recurrence | 12 Month | |
| AFS + MED | MED | Disposable Suture Device | T: L3/L4 = 6, L4/L5 = 21, L5/S1 = 15 C: L3/L4 = 4, L4/L5 = 20, L5/S1 = 17 | Operative time Blood loss LOS VAS score ODI score Recurrence | T: 14.13 ± 0.92 Month C: 13.31 ± 1.31 Month | |
| AFS + PTED | PTED | Disposable Suture Device | T: L2/L3 = 1, L3/L4 = 11, L4/L5 = 16, L5/S1 = 18 C: L2/L3 = 2, L3/L4 = 14, L4/L5 = 17, L5/S1 = 17 | Operative time Blood loss VAS score Recurrence | 12 Month | |
| AFS + MED | MED | NA | NA | VAS score ODI score Recurrence | 12 Month | |
| AFS + PELD | PELD | Disposable Suture Device | T: L4/L5 = 20, L5/S1 = 15 C: L4/L5 = 27, L5/S1 = 20 | Operative time Incision length Blood loss LOS VAS score ODI score Disc height Recurrence | 18 Month | |
| AFS + TELD | TELD | Disposable Suture Device | T: L4/L5 = 12, L5/S1 = 18 C: L4/L5 = 10, L5/S1 = 20 | Operative time VAS score ODI score Recurrence | 15 ± 8 Month | |
| AFS + Discectomy | Discectomy | Disposable Suture Device | NA | Operative time Blood loss Recurrence | 6 Month | |
| AFS + PTED | PTED | Disposable Suture Device (EFIT-Ⅱ) | T: L3/L4 = 6, L4/L5 = 20, L5/S1 = 11 C: L3/L4 = 5, L4/L5 = 17, L5/S1 = 8 | VAS score ODI score Recurrence | 14.2 ± 1.7 Month | |
| AFS + TELD | TELD | Disposable Suture Device | T: L4/L5 = 15, L5/S1 = 23 C: L4/L5 = 26, L5/S1 = 19 | Operative time Blood loss VAS score ODI score Recurrence | 16.82 ± 3.75 Month | |
| AFS + MED | MED | Disposable Suture Device | T: L3/L4 = 5, L4/L5 = 14, L5/S1 = 13 C: L3/L4 = 4, L4/L5 = 18, L5/S1 = 14 | Operative time Blood loss LOS VAS score JOA score ODI score Recurrence | 4.21 ± 0.54 Year | |
| AFS + TELD | TELD | Disposable Suture Device | T: L3/L4 = 1, L4/L5 = 20, L5/S1 = 19 C: L3/L4 = 3, L4/L5 = 22, L5/S1 = 17 | Operative time LOS VAS score ODI score Recurrence | 18 Month | |
| AFS + MED | MED | Disposable Suture Device | T: L3/L4 = 3 L4/L5 = 19 L5/S1 = 10 C: L3/L4 = 3 L4/L5 = 15 L5/S1 = 15 | Operative time Blood loss LOS Recurrence | NA | |
| AFS + Discectomy | Discectomy | Disposable Suture Device (FAST-FIX) | T: L4/L5 = 20, L5/S1 = 15 C: L4/L5 = 27, L5/S1 = 20 | Operative time Blood loss VAS score ODI score Disc height Recurrence | 24 Month | |
| AFS + OD | OD | Disposable Suture Device | T: L4/L5 = 23, L5/S1 = 16 C: L4/L5 = 33, L5/S1 = 14 | Operative time Incision length Blood loss LOS JOA score | NA | |
| AFS + TELD | TELD | Disposable Suture Device | L3/L4 = 15 L4/L5 = 37, L5/S1 = 23 | VAS score ODI score Recurrence | 6 Month | |
| AFS + Discectomy | Discectomy | Disposable Suture Device (FAST-FIX) | NA | Operative time Blood loss LOS VAS score ODI score Recurrence | 6 Month | |
| AFS + Discectomy | Discectomy | Disposable Suture Device | T: L4/L5 = 4, L5/S1 = 6 C: L4/L5 = 9, L5/S1 = 3 | Operative time Incision length Blood loss LOS VAS score ODI score Recurrence | 21.3 ± 7.6 Month | |
| AFS + MED | MED | Disposable Suture Device | T: L3/L4 = 23, L4/L5 = 24, L5/S1 = 13 C: L3/L4 = 21, L4/L5 = 23, L5/S1 = 16 | Operative time Blood loss VAS score ODI score Disc height Recurrence | 6 Month | |
| AFS + OD | OD | Disposable Suture Device | NA | VAS score JOA score ODI score Disc height | T: 13.5 Month C: 15 Month | |
| AFS + MED | PTED | Disposable Suture Device | T: L3/L4 = 6, L4/L5 = 26, L5/S1 = 19 C: L3/L4 = 6, L4/L5 = 25, L5/S1 = 23 | Operative time LOS VAS score ODI score Disc height Recurrence Complication | 36 Month | |
| AFS + PELD | PELD | NA | NA | Operative time Blood loss VAS score ODI score Recurrence | 16.1 Month | |
| AFS + Discectomy | Discectomy | Disposable Suture Device | NA | VAS score ODI score Recurrence | 12 Month | |
| AFS + MED | MED | Disposable Suture Device (FAST-FIX) | T: L3/L4 = 3, L4/L5 = 24, L5/S1 = 15 C: L3/L4 = 5, L4/L5 = 31, L5/S1 = 19 | Operative time Blood loss VAS score ODI score Disc height Recurrence | 27.1 Month | |
| AFS + MED | MED | Disposable Suture Device | T: L4/L5 = 7, L5/S1 = 15 C: L4/L5 = 10, L5/S1 = 18 | VAS score | 6 Month | |
| AFS + MED | MED | Disposable Suture Device (FAST-FIX) | T: L3/L4 = 5, L4/L5 = 20, L5/S1 = 14 C: L3/L4 = 6, L4/L5 = 22, L5/S1 = 16 | Operative time Blood loss VAS score ODI score Disc height Recurrence | 27.8 Month | |
| AFS + Discectomy | Discectomy | Disposable Suture Device (FAST-FIX) | T: L4/L5 = 12, L5/S1 = 9 C: L4/L5 = 14, L5/S1 = 10 | Operative time Blood loss VAS score ODI score Recurrence | 12 Month | |
| AFS + Discectomy | Discectomy | Disposable Suture Device | T: L3/L4 = 4, L4/L5 = 20, L5/S1 = 15 C: L3/L4 = 3, L4/L5 = 21, L5/S1 = 13 | Operative time Blood loss VAS score ODI score Recurrence | 24 Month | |
| AFS + MED | MED | Disposable Suture Device | NA | Operative time Blood loss Recurrence | 18 Month | |
| AFS + MED | PTED | Disposable Suture Device | T: L4/L5 = 13, L5/S1 = 7 C: L4/L5 = 10, L5/S1 = 6 | Operative time Incision length Blood loss LOS VAS score JOA score ODI score | 12.5 ± 1.82 Month | |
| AFS + MED | MED | Disposable Suture Device | NA | Blood loss VAS score ODI score Recurrence | NA | |
| AFS + OD | OD | Disposable Suture Device | NA | Operative time Blood loss LOS | 6 Month | |
| AFS + Discectomy | Discectomy | Disposable Suture Device | T: L3/L4 = 2, L4/L5 = 13, L5/S1 = 10 C: L3/L4 = 2, L4/L5 = 13, L5/S1 = 8 | Operative time Incision length Blood loss VAS score ODI score Recurrence Complication | 12 Month | |
| AFS + OD | OD | Disposable Suture Device | T: L4/L5 = 18, L5/S1 = 14 C: L4/L5 = 17, L5/S1 = 15 | Operative time Incision length Blood loss LOS VAS score ODI score Complication | 18 Month | |
| AFS + Discectomy | Discectomy | Disposable Suture Device | NA | Operative time Blood loss LOS VAS score ODI score | 12 Month | |
| AFS + MED | MED | Disposable Suture Device | T: L4/L5 = 14, L5/S1 = 16 C: L4/L5 = 13, L5/S1 = 17 | Operative time Blood loss VAS score JOA score ODI score | 6 Month | |
| AFS + Discectomy | Discectomy | Disposable Suture Device | T: L4/L5 = 18, L5/S1 = 12 C: L4/L5 = 15, L5/S1 = 13 | Operative time Incision length Blood loss LOS VAS score ODI score Recurrence | 14.5 ± 1.3 Month | |
| AFS + OD | OD | Disposable Suture Device | T: L4/L5 = 23, L5/S1 = 16 C: L4/L5 = 33, L5/S1 = 14 | Operative time Incision length Blood loss LOS Recurrence Complication | 6 Month | |
| AFS + MED | MED | Disposable Suture Device | T: L4/L5 = 21, L5/S1 = 15 C: L4/L5 = 18, L5/S1 = 15 | Operative time Blood loss VAS score ODI score Recurrence | 18–32 Month | |
| AFS + OD | OD | Disposable Suture Device | L3/L4 = 8, L4/L5 = 45, L5/S1 = 39 | Operative time Blood loss JOA score Recurrence Complication | 18 Month | |
| AFS + MED | MED | Disposable Suture Device (FAST-FIX) | T: L3/L4 = 4, L4/L5 = 63, L5/S1 = 51 C: L3/L4 = 6, L4/L5 = 89, L5/S1 = 77 | Operative time Blood loss VAS score ODI score Disc height Recurrence | T: 26.2 ± 10.4 Month C: 30.4 ± 11.2 Month | |
| AFS + OD | OD | Disposable Suture Device | T: L4/L5 = 8, L5/S1 = 4 C: L4/L5 = 10, L5/S1 = 4 | Operative time Incision length Blood loss LOS VAS score ODI score Recurrence | 12 Month | |
| AFS + Discectomy | Discectomy | Disposable Suture Device | NA | VAS score JOA score ODI score Disc height | 12–20 Month | |
| AFS + MED | MED | Disposable Suture Device (FAST-FIX) | T: L3/L4 = 2, L4/L5 = 27, L5/S1 = 22 C: L3/L4 = 7, L4/L5 = 92, L5/S1 = 69 | Operative time Blood loss Recurrence | 28 Month | |
| AFS + Discectomy | Discectomy | Xclose | T: L2/L3 or L3/L4 = 29, L4/L5 = 193, L5/L6 or L6/S1 = 2, L5/S1 = 273 C: L2/L3 or L3/L4 = 19, L4/L5 = 98, L5/L6 or L6/S1 = 1, L5/S1 = 146 | Recurrence Complication | 2 Year | |
| AFS + Discectomy | Discectomy | Disposable Suture Device | T: L3/L4 = 4, L4/L5 = 10, L5/S1 = 8 C: L3/L4 = 8, L4/L5 = 18, L5/S1 = 9 | JOA score Recurrence | 2.5 Year |
Intervention characteristics of included studies.
AFS, annulus fibrosus suture; AUSS, arthroscopic-assisted uni-portal spinal surgery; C, control group; JOA, japanese orthopedic association; LOS, length of stay; MED, microendoscopic discectomy; NA, not available; OD, open discectomy; ODI, oswestry disability index; PEID, percutaneous endoscopic interlaminar discectomy; PELD, percutaneous endoscopic lumbar diskectomy; PTED, percutaneous transforaminal endoscopic discectomy; T, treatment group; TELD, transforaminal endoscopic lumbar discectomy; VAS, visual analogue scale.
TABLE 3
| Outcomes | Subgroups | Number of studies | Effect estimate (MD or SMD or RR) | Heterogeneity | P-value for pooled result | Group deference (P-value) | |
|---|---|---|---|---|---|---|---|
| P value | I2 (%) | ||||||
| Operative time | Total | 46 | 4.85 [2.79 to 6.92] | <0.00001 | 94 | <0.00001 | |
| RCT | 12 | 1.22 [-3.79 to 6.24] | <0.00001 | 95 | 0.63 | 0.08 | |
| Non-RCT | 34 | 6.11 [4.02 to 8.21] | <0.00001 | 92 | <0.00001 | ||
| Incision length | Total | 13 | 0.00 [-0.03 to 0.04] | 0.11 | 34 | 0.84 | |
| Blood loss | Total | 41 | 0.32 [-1.17 to 1.80] | <0.00001 | 93 | 0.67 | |
| RCT | 11 | −5.90 [-13.66 to 1.86] | <0.00001 | 97 | 0.14 | 0.05 | |
| Non-RCT | 30 | 1.95 [0.82 to 3.08] | <0.00001 | 83 | 0.0007 | ||
| LOS | Total | 23 | 0.06 [-0.49 to 0.62] | <0.00001 | 96 | 0.82 | |
| RCT | 4 | −0.42 [-1.53 to 0.69] | <0.00001 | 89 | 0.46 | 0.37 | |
| Non-RCT | 19 | 0.17 [-0.49 to 0.62] | <0.00001 | 97 | 0.60 | ||
| VAS score | Total | 47 | −0.24 [-0.33 to −0.14] | <0.00001 | 93 | <0.00001 | |
| RCT | 9 | −0.34 [-0.57 to −0.12] | <0.00001 | 95 | 0.003 | 0.31 | |
| Non-RCT | 38 | −0.21 [-0.32 to −0.10] | <0.00001 | 92 | 0.0002 | | |
| 1-month follow-up | 12 | 0.04 [-0.09 to 0.18] | 0.02 | 51 | 0.53 | 0.01 | |
| 3-month follow-up | 33 | −0.19 [-0.39 to 0.01] | <0.00001 | 95 | 0.07 | ||
| 6-month follow-up | 22 | −0.28 [-0.46 to −0.09] | <0.00001 | 94 | 0.003 | ||
| 12-month follow-up | 26 | −0.23 [-0.38 to −0.09] | <0.00001 | 91 | 0.002 | ||
| JOA score | Total | 12 | 0.85 [-0.23 to 1.93] | <0.00001 | 98 | 0.12 | |
| RCT | 1 | 0.17 [-1.41 to 1.75] | - | - | 0.83 | 0.46 | |
| Non-RCT | 11 | 0.91 [-0.22 to 2.04] | <0.00001 | 99 | 0.12 | | |
| 1-month follow-up | 1 | 0.09 [-0.90 to 1.08] | - | - | 0.86 | 0.28 | |
| 3-month follow-up | 3 | 1.00 [-1.29 to 3.29] | 0.001 | 85 | 0.39 | ||
| 6-month follow-up | 5 | 1.45 [0.23 to 2.67] | <0.00001 | 99 | 0.02 | ||
| 12-month follow-up | 7 | 1.33 [0.15 to 2.51] | <0.00001 | 99 | 0.03 | ||
| ODI score | Total | 44 | −0.94 [-2.37 to 0.49] | <0.00001 | 99 | 0.20 | |
| RCT | 9 | −1.21 [-2.66 to 0.23] | <0.00001 | 92 | 0.10 | 0.76 | |
| Non-RCT | 35 | −0.85 [-2.63 to 0.93] | <0.00001 | 100 | 0.35 | | |
| 1-month follow-up | 10 | −0.74 [-1.32 to −0.17] | 0.59 | 0 | 0.01 | 0.28 | |
| 3-month follow-up | 30 | −1.22 [-1.92 to −0.52] | <0.00001 | 86 | 0.0006 | ||
| 6-month follow-up | 20 | −1.13 [-1.91 to −0.34] | <0.00001 | 88 | 0.005 | ||
| 12-month follow-up | 26 | −0.15 [-1.08 to 0.78] | <0.00001 | 96 | 0.75 | ||
| Disc height | Total | 11 | 1.36 [0.73 to 2.00] | <0.00001 | 96 | <0.0001 | |
| RCT | 1 | −0.41 [-0.77 to −0.05] | - | - | 0.03 | <0.00001 | |
| Non-RCT | 10 | 1.55 [0.89 to 2.20] | <0.00001 | 96 | <0.00001 | ||
| Recurrence | Total | 48 | 0.34 [0.27 to 0.42] | 0.99 | 0 | <0.00001 | |
| Complication | Total | 9 | 0.80 [0.61 to 1.06] | 0.84 | 0 | 0.12 | |
Summary data and analyses.
Risk of bias assessment
The risk of bias for each included RCTs (; ; ; ; ; ; ; ; ; ; ; ; ; ) was evaluated using the RoB-2 instrument, and the findings are presented in Supplementary Figure S1. Among these, five trials were judged to be at low overall risk of bias (; ; ; ; ). Eight trials raised some concerns, primarily in the domains of bias due to deviations from intended interventions (lack of surgeon blinding) and bias in measurement of the outcome (lack of patient blinding for subjective outcomes) (; ; ; ; ; ; ; ). One study was judged to be at high risk due to concerns regarding the randomization process (). The ROBINS-I tool was adopted to assess the quality of evidence of included non-RCTs (; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ), as shown in Supplementary Figure S2. Thirteen studies were rated at low overall risk of bias (; ; ; ; ; ; ; ; ; ; ; ; ). The twenty-eight studies were rated at moderate risk (; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ). The most prevalent sources of potential bias in these studies were bias due to confounding (differences in surgeon experience), bias in the selection of participants (associated with the retrospective cohort design), and selective reporting of outcomes. Three studies were rated at serious risk of bias, mainly due to issues such as significant deviations from the intended intervention or substantial loss to follow-up (; ; ).
Meta-analysis results
Operative time
A total of 46 studies with 4,413 participants reported operative time in the study. There was significant heterogeneity across studies (P < 0.00001, I2 = 94%). This result indicates that statistically significant differences in operative time exist between the two groups (MD = 4.85, 95% CI: 2.79 to 6.92, P < 0.00001) (Supplementary Figure S3).
Further subgroup analyses were conducted based on variations in study design to explore the influence of these variables on the therapeutic effect. These analyses revealed that the overall findings were robust, although a minority of subgroups did not show significant benefits. Results revealed no significant impact on operative time in subgroups of RCT studies (MD = 1.22, 95% CI: −3.79 to 6.24, P = 0.63) (Table 3; Supplementary Figure S4).
Incision length
A total of 13 studies with 831 participants reported incision length in the study. There was low heterogeneity across studies (P = 0.11, I2 = 34%). This result indicates that there are no statistically significant differences in incision length between the two groups (MD = 0.00, 95% CI: −0.03 to 0.04, P = 0.84) (Supplementary Figure S5).
Blood loss
A total of 41 studies with 3,913 participants reported blood loss in the study. There was significant heterogeneity across studies (P < 0.00001, I2 = 93%). This result indicates that there are no statistically significant differences in blood loss between the two groups (MD = 0.32, 95% CI: −1.17 to 1.80, P = 0.67) (Supplementary Figure S6).
Subgroup analyses were conducted according to different study designs. Pooled analysis showed that the significant impact on blood loss in subgroups of Non-RCT studies (MD = 1.95, 95% CI: 0.82 to 3.08, P = 0.0007) (Table 3; Supplementary Figure S7).
LOS
A total of 23 studies with 1824 participants reported LOS in the study. There was significant heterogeneity across studies (P < 0.00001, I2 = 96%). This result indicates that there are no statistically significant differences in LOS between the two groups (MD = 0.06, 95% CI: −0.49 to 0.62, P = 0.82) (Supplementary Figure S8).
Further subgroup analysis was conducted. The results were consistent across all subgroups, confirming that these variables had no significant effect on reducing the LOS (Table 3; Supplementary Figure S9).
VAS score
A total of 47 studies with 4,090 participants reported the VAS score in the study. There was significant heterogeneity across studies (P < 0.00001, I2 = 93%). This result indicates that statistically significant differences in VAS score between the two groups (MD = −0.24, 95% CI: −0.33 to −0.14, P < 0.00001) (Supplementary Figure S10).
Subgroup analyses were conducted according to different study designs and lengths of follow-up. These findings indicate that the overall results remain robust, despite the lack of statistically significant effects in a minority of subgroups. When stratified according to study design, the subgroup analyses yielded results consistent with the overall estimate, also demonstrating statistical significance. However, in the subgroup analysis stratified by follow-up time, no statistically significant differences in VAS score between the two groups were observed at the 1-month (MD = 0.04, 95% CI: −0.09 to 0.18, P = 0.53) and 3-month postoperative (MD = −0.19, 95% CI: −0.39 to 0.01, P = 0.07) follow-ups (Table 3; Supplementary Figures S11-S12).
JOA score
A total of 12 studies with 1,279 participants reported the JOA score in the study. There was significant heterogeneity across studies (P < 0.00001, I2 = 98%). This result indicates that there are no statistically significant differences in JOA score between the two groups (MD = 0.85, 95% CI: −0.23 to 1.93, P = 0.12) (Supplementary Figure S13).
Subgroup analysis based on study design demonstrated results consistent with the overall estimate, without statistical significance for either. Conversely, a statistically significant difference between the two groups emerged at the 6-month and 12-month postoperative follow-ups. In contrast, the analysis demonstrated statistically significant differences in JOA scores between the groups at the 6-month (MD = 1.45, 95% CI: 0.23 to 2.67, P = 0.02) and 12-month postoperative (MD = 1.33, 95% CI: 0.15 to 2.51, P = 0.03) assessments (Table 3; Supplementary Figures S14-S15).
ODI score
A total of 44 studies with 3,770 participants reported the ODI score in the study. There was significant heterogeneity across studies (P < 0.00001, I2 = 99%). This result indicates that there are no statistically significant differences in ODI score between the two groups (MD = −0.94, 95% CI: −2.37 to 0.49, P = 0.20) (Supplementary Figure S16).
Subgroup analysis based on study design demonstrated results consistent with the overall estimate, without statistical significance for either. Conversely, a statistically significant difference between the two groups emerged at the 1-month, 6-month, and 12-month postoperative follow-ups. In contrast, the analysis demonstrated statistically significant differences in ODI scores between the groups at the 1-month (MD = −0.74, 95% CI: −1.32 to −0.17, P = 0.01), 3-month (MD = −1.22, 95% CI: −1.92 to −0.52, P = 0.0006) and 6-month postoperative (MD = −1.13, 95% CI: −1.91 to −0.34, P = 0.005) assessments (Table 3; Supplementary Figures S17-S18).
Disc height
A total of 11 studies with 1,176 participants reported disc height in the study. There was significant heterogeneity across studies (P < 0.00001, I2 = 96%). This result indicates that statistically significant differences in disc height exist between the two groups (SMD = 1.36, 95% CI: 0.73 to 2.00, P < 0.0001) (Supplementary Figure S19).
Additional stratified analyses revealed that the effect estimates for all subgroups remained congruent with the overall result (Table 3; Supplementary Figure S20).
Recurrence
A total of 48 studies with 4,999 participants reported recurrence in the study. There was low significant heterogeneity across studies (P = 0.99, I2 = 0%). This result indicates that statistically significant differences in recurrence exist between the two groups (RR = 0.34, 95% CI: 0.27 to 0.42, P < 0.00001) (Supplementary Figure S21).
Complication
A total of nine studies with 1,466 participants reported complication in the study. There was low significant heterogeneity across studies (P = 0.84, I2 = 0%). This result indicates that no statistically significant differences in complication exist between the two groups (RR = 0.80, 95% CI: 0.61 to 1.06, P = 0.12) (Supplementary Figure S22).
Sensitivity analysis
To verify the reliability of the results in this study, sensitivity analyses were conducted on various outcome indicators, including operative time, blood loss, LOS, VAS score, JOA score, ODI score, and disc height. For blood loss, the effect size shifted following the exclusion of Tian’s study () (I2 = 79%, P = 0.002), indicating it may be the source of heterogeneity. For the JOA score, the effect size changed after excluding Zhou’s study () (I2 = 98%, P = 0.04) and Jiao’s study () (I2 = 98%, P = 0.0007). Similarly, for the JOA score, the results became significant after excluding the adolescent population studies (; ). Sensitivity analyses of other outcomes confirmed the stability of pooled effect estimates. Complete sensitivity analysis data are provided in Supplementary Tables S1-S7.
Publication bias
For the outcomes of operative time, incision length, blood loss, LOS, VAS score, JOA score, ODI score, disc height, and recurrence, asymmetry was observed in the funnel plots. Therefore, we performed an Egger’s test to confirm the risk of publication bias. However, Egger’s test did not detect significant bias for operative time, incision length, blood loss, LOS, VAS score, JOA score, and ODI score, suggesting stable effect estimates for these outcomes. For disc height and recurrence, Egger’s test suggested potential bias. Therefore, the Trim and Fill method was used for correction. The effect size after disc height correction was (SMD = 2.04, 95% CI: 1.01 to 4.09, P = 0.046), and the effect size after recurrence correction was (RR = 0.52, 95% CI: 0.42 to 0.66, P < 0.001). Detailed results are provided in Supplementary Figures S23-S31 and Supplementary Table S8.
GRADE evaluation
Based on the principles of the GRADE evaluation, we assessed the quality of the evidence in terms of operative time, incision length, blood loss, LOS, VAS score, JOA score, ODI score, disc height, recurrence, and complication. According to Supplementary Table S9, the evidence for the incision length was classified as moderate quality, JOA score and complication were classified as low quality, while the other evidence was of very low quality.
Discussion
LDH is a common clinical spinal disorder. With societal acceleration and evolving lifestyles, its prevalence has been steadily increasing (; ; ). The surgical management of LDH is undergoing continuous evolution, driven by advances in mezdical technology. Nevertheless, achieving better efficacy, improved patient prognosis, and reducing postoperative recurrence rates persists as key objectives in clinical practice (; ). Some studies have found that although discectomy relieves nerve root compression, it can exacerbate the annulus fibrosus defect, thereby potentially increasing the risk of symptom recurrence and reoperation (; ; ). Therefore, intraoperative restoration of annulus fibrosus integrity is of critical importance. The annular closure device typically consists of a woven polymer mesh that is anchored into the adjacent vertebral bodies with titanium bone anchors (). Following discectomy, the device is placed directly into the annulus fibrosus defect. This helps preserve residual nucleus pulposus, maintain disc height, and promote natural healing, thereby slowing degenerative progression (; ). Concurrently, it restores disc integrity of the disc space and reduces the risk of recurrent herniation (; ). However, we cannot ignore the potential issues of device migration, implantation failure, and related complications (; ; ). An alternative approach involves the direct suturing of the damaged annulus fibrosus during surgery, but has yielded inconsistent clinical efficacy (; ; ). Accordingly, the present study was conducted to assess the clinical value of the AFS technique in the surgical management of LDH.
In this meta-analysis, 58 studies (; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ) were enrolled, which included 5,765 patients with LDH. Our analysis demonstrates significant differences in operative time, VAS score, disc height, and recurrence between the surgery with AFS and the conventional surgery. However, no significant differences were observed between approaches in the incision length, blood loss, LOS, JOA score, ODI score, and complication.
The study results demonstrated that the AFS group had a longer operative time than the control group, with a statistically significant difference. In the AFS group, after removing the herniated nucleus pulposus, the ruptured annulus fibrosus was cleaned and sutured using a suitable method. However, the control group did not receive any treatment for the ruptured annulus fibrosus. Though the surgeries for both groups were performed by the same experienced surgeon, the AFS technique is still emerging and can be a challenge for surgeons, contributing to the longer operative time (; ). It’s anticipated that as the AFS technique advances and becomes more widespread, the operative time gap between the groups will decrease. Concerning operative time, the heterogeneity observed may be attributed to the fact that some research centers have limited experience with the AFS technique and are still on a slow learning curve. Additionally, most studies do not clarify whether anesthesia administration and patient positioning times are included in the operative time.
In this systematic review and meta-analysis, we found no significant differences between the two groups in terms of incision length, blood loss, and LOS. A single-center RCT involving 80 patients with LDH indicated similar incision lengths for percutaneous transforaminal endoscopic discectomy combined with AFS and percutaneous transforaminal endoscopic discectomy alone (). Similarly, Liu’s study showed that the endoscopic AFS technique does not cause extra patient injury (; ).
Greater blood loss in LDH surgery is linked to higher perioperative complication risks. Thus, blood loss is an important outcome indicator of surgical safety and quality. Some scholars think that, as both surgeries are done endoscopically, the AFS technique does not require more removal of the facet joint and ligamentum flavum, so it will not cause extra trauma (). Similarly, compared with the control group, the AFS group does not increase blood loss (). This may be because the transforaminal endoscopic technique allows timely hemostasis and provides a clear surgical field, creating good conditions for AFS and effectively avoiding medical injury in the operation process. Moreover, the annulus fibrosus has collagen fibers in concentric circles and lacks a significant blood supply.
The lack of difference in LOS may be due to the similar impacts of the two techniques on postoperative recovery and overall health, leading to comparable hospitalization times. A relevant RCT has compared percutaneous transforaminal endoscopic discectomy and percutaneous transforaminal endoscopic discectomy combined with AFS in elderly patients with LDH and found no significant difference in LOS. This indicates that AFS adjuvant therapy does not bring additional risks or require a longer recovery time. It’s important to note that there are differences in hospitalization management policies across hospitals.
Lumbar pain is a primary symptom of patients with LDH, so observing pain changes in patients is crucial. The VAS score, known for its simplicity and patient acceptance, is widely used in clinical research. Studies indicate that surgery combined with AFS can effectively alleviate pain symptoms in patients. Chen’s study found that this combined approach significantly reduces both the lumbar VAS score and leg VAS score (). Similarly, Yao’s study observed effective pain relief after performing interrupted sutures on the ruptured annulus fibrosus following nucleotomy (). However, some studies have not found AFS to be significantly advantageous in postoperative pain improvement (). LDH occurs when the annulus fibrosus ruptures due to various reasons, allowing the nucleus pulposus to directly compress or stretch the nerve root (; ). The nucleus pulposus contains a variety of inflammatory mediators like PLA2, histamine, lactate, substance P, and others. When these mediators come into contact with nerve roots due to herniation, they trigger the release of other inflammatory factors, causing persistent pain (; ). Both treatments relieve pain by removing the herniated nucleus pulposus to decompress nerve roots, so there is no difference in the short-term efficacy observation. Xu’s research compared the early pain-relieving effects of AFS combined with nucleotomy and nucleotomy alone in 65 participants and found them similar (). Our study also found no significant differences in early postoperative VAS score between the two groups, possibly due to their similar main objectives. Zhu and his team found that many patients still experience pain after surgery, likely due to residual nucleus pulposus debris irritating nerve roots (). The nucleus pulposus, as an immune-privileged tissue that is usually isolated from systemic circulation, can trigger autoimmune responses when exposed to the immune system through herniation. Intraoperative application of AFS as an adjunctive procedure enables immediate closure of annular defects, thereby accelerating the repair process at the rupture site. Meanwhile, this technique closes the channel between the nucleus pulposus tissue and the spinal canal, effectively blocking the stimulation of nerve roots by residual nucleus pulposus fragments. This creates a relatively enclosed internal environment within the intervertebral disc, reducing the release of inflammatory factors and minimizing chemical irritation to nerve roots, thereby relieving postoperative pain. Without intraoperative repair of the annulus fibrosus, its rupture persists with limited self-healing ability, requiring a prolonged fibrosus scar to achieve this. During this period, residual nucleus pulposus remains exposed to the immune system, where systemic circulation recognizes it as a foreign antigen, triggering immune attacks (). Some researchers suggest that persistent inflammatory mediator stimulation at unrepaired annulus fibrosus defects contributes to chronic postoperative pain (). An RCT demonstrated that adjunctive AFS can reduce serum levels of β-endorphin, prostaglandin E2, and 5-hydroxytryptamine (). Additionally, Chen’s study compared concentrations of TNF-α and phospholipase A2 in serum and drainage fluid before and after surgery with versus without AFS, finding that combined AFS significantly reduces inflammatory factor release ().
The JOA score comprehensively evaluates the clinical improvement of patients across four domains, including subjective symptoms, clinical signs, daily living ability, and bladder function. In Tang’s study, both groups showed increased postoperative JOA scores, yet the AFS group had a higher score (). This implies that AFS positively enhances lumbar functional recovery, physical performance, and quality of life. Similarly, a single-center retrospective study of 92 patients demonstrated higher JOA scores in those receiving adjunctive AFS compared to controls (). This may be attributed to AFS restoring postoperative integrity of the annulus fibrosus, which facilitates early postoperative mobilization and functional exercise, thereby shortening the recovery period.
The ODI is clinically used to assess the impact of low back pain on daily living. Both patient groups showed similar improvements in ODI. An RCT revealed that patients receiving adjunctive AFS improved ODI at 6, 12, and 18 months postoperatively (). Hu’s study found that both surgeries, combined with AFS and surgery alone, improved ODI in patients, with no significant difference between groups 1 year post-operation (). This aligns with a meta-analysis comparing discectomy with annulus fibrosus repair versus discectomy alone in LDH patients, which found no significant difference in ODI improvement between techniques (). This meta-analysis reinforces our observation that AFS is a safe adjunctive approach, yielding comparable clinical ODI improvement, though its efficacy requires further validation through large-scale studies.
Our study revealed significant differences in postoperative disc height between the surgery combined with AFS and the surgery group, consistent with multiple studies (; ). Li and his team analyzed 285 single-level LDH patients treated with percutaneous transforaminal endoscopic discectomy, finding that a severe degree of disc degeneration, smaller disc height index, and larger postoperative annulus fibrosus defects may be associated with early recurrence (). Scholars have suggested that AFS alone may not provide significant additional benefits for postoperative pain and functional recovery, but could help maintain disc height (). The annulus fibrosus comprises inner and outer layers. The inner layer bears hydrostatic pressure from the nucleus pulposus, while the outer layer restricts excessive spinal motion and withstands tensile forces (; ). Ren’s study demonstrated that circumferential suturing of annulus fibrosus defects during microendoscopic discectomy preserves disc height (). Maintaining disc height supports spinal stability and reduces adjacent segment degeneration. Fu’s research also reported that surgery combined with AFS effectively improves disc height and mobility in young patients, promoting early functional recovery (). A healthy annulus fibrosus exhibits strong contractility to cushion spinal loads and restore disc shape, playing a vital role in spinal mechanics (). An animal study found that annulus fibrosus repair limits motion in surgical segments, enhancing spinal stability (). Similarly, Wang’s team observed in a goat model that AFS preserves disc height and delays disc degeneration ().
One of the key findings of our investigation is the reduced recurrence in patients undergoing AFS. Primary surgery may alter local anatomy, induce epidural fibrosis, and promote scar tissue formation, all of which increase the technical difficulty and risks of revision surgery. Additionally, these factors impose physical and psychological burdens on patients. Studies have identified age, Pfirrmann grade, and rehabilitation duration as factors influencing recurrence after percutaneous transforaminal endoscopic discectomy (). Zhao et al. further highlighted age, disease duration, Pfirrmann grade, annulus fibrosus defects, and incomplete nucleus pulposus removal as recurrence risk factors, corroborated by other scholars (; ). Yao et al. reported 35 cases with no recurrence and reoperations over a 2-year follow-up after nucleotomy combined with AFS, with imaging showing no accelerated disc degeneration (). Ding’s study similarly demonstrated that AFS after nucleotomy significantly reduces recurrence risk and reoperation demand (). The extent of nucleus pulposus removal during surgery is critical for ensuring therapeutic efficacy and preventing recurrence. Excessive intraoperative removal risks disc height loss and accelerated disc degeneration, potentially compromising spinal stability. Conversely, limited nucleus pulposus removal without annulus fibrosus repair may lead to postoperative recurrence in some patients due to residual nucleus pulposus tissue, inflammatory mediators, and torn annular fragments. AFS technique restores annulus fibrosus mechanical integrity, facilitating postoperative annulus fibrosus healing and maintaining intervertebral disc function. On the one hand, it relieves nerve root compression while preserving healthy nucleus pulposus to delay degeneration. On the other hand, it prevents postoperative physical and chemical irritation of nerve roots, thereby minimizing recurrence. Finally, no significant difference in complication between the two surgical approaches. As both surgeries involve careful spinal structure management, they consequently yield comparable safety results. This indicates that adjunctive AFS does not cause additional harm, supporting its potential as a safe supplement to LDH surgery.
Furthermore, significant publication bias was detected for the two significant outcomes of disc height and recurrence. This phenomenon may be attributed to the tendency of smaller studies to report exaggerated effect sizes, leading to their preferential publication, alongside methodological heterogeneities such as variations in assessment timing. The statistical significance of these findings persisted after trim-and-fill correction. Nevertheless, caution is advised in interpreting these outcomes due to the initial presence of bias.
Strengths and limitations
To the best of our knowledge, this is the first meta-analysis and systematic review evaluating the efficacy and safety of surgery combined with AFS for LDH from operative time, incision length, blood loss, LOS, VAS score, JOA score, ODI score, disc height, recurrence, and complication. Despite significant findings, our study has several limitations. First, most of the studies included were non-randomized, which may introduce bias and confounding factors. There are some differences in RCTs and non-RCTs’ results that should be kept in mind while interpreting these results. Second, some outcomes are based on scale scores, which may be subject to varying interpretations by researchers and patients, potentially influencing the results. These study results should be interpreted with caution. Third, there was a high level of heterogeneity in some outcomes, such as operative time, which could be due to patient populations, surgical protocols, annulus fibrosus defect severity, extent of nucleus removal, and follow-up duration. Future studies could employ meta-regression analysis to further explore the sources of heterogeneity. Fourth, while all studies utilized AFS, variations in incision direction, incision length, suturing methods, and stitch spacing might impact findings. Meanwhile, as all included studies were conducted in China, the generalizability of the findings to other populations and healthcare contexts may be limited. To enhance the universality of the findings, it is recommended that verification studies be carried out in multiple regions in the future. Fifth, surgical outcomes depend on the surgeon’s technical skill and experience, which vary across studies and introduce bias. Sixth, the overall certainty of evidence for most outcomes, as evaluated by the GRADE framework, was rated as low or very low. These ratings were consistently downgraded due to serious concerns regarding study design (inclusion of multiple non-randomized designs), risk of bias, and inconsistency (substantial unexplained statistical heterogeneity). Therefore, further high-quality RCTs are necessary to confirm our findings.
Prospects for future research
Future studies should optimize experimental protocols in the following aspects. First, current research lacks data on the long-term efficacy and potential complications of AFS. Future studies should use rigorous control groups, randomization, and high-quality blinding to enhance the reliability. Second, during surgery, surgeons should minimize puncture attempts and employ gentle, gradual knot tying to avoid secondary annular damage. Excessive punctures may compromise annular integrity, impairing surgical outcomes. Current physical suturing methods require refinement to enhance closure effectiveness. Finally, while AFS techniques focus on restoring mechanical annulus fibrosus integrity, future research should integrate cell therapy, gene therapy, and tissue engineering to restore the annulus fibrosus’s physiological function.
Conclusion
In conclusion, current evidence suggests that AFS may offer potential benefits in LDH surgery. However, given the overall low quality of the included studies, these findings should be interpreted with caution. More large-scale, multicenter RCTs are needed in the future to confirm the clinical efficacy and safety of AFS as an adjuvant therapy for LDH.
Statements
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding authors.
Author contributions
WO: Conceptualization, Visualization, Methodology, Formal Analysis, Writing – original draft, Data curation. GG: Investigation, Writing – original draft, Software, Data curation, Validation, Conceptualization. YS: Validation, Visualization, Resources, Formal Analysis, Writing – original draft, Supervision. HJ: Writing – original draft, Data curation, Software, Investigation, Formal Analysis. LC: Writing – review and editing, Investigation. SY: Supervision, Writing – review and editing.
Funding
The author(s) declared that financial support was received for this work and/or its publication. National Natural Science Foundation of China (Grant Nos. 82575113 and 82174402) and Hunan Provincial Natural Science Foundation (Grant Nos. 2023JJ40504 and 2023JJ60345).
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fbioe.2025.1741738/full#supplementary-material
Abbreviations
AFS, Annulus fibrosus suture; CI, Confidence interval; GRADE, Grading of Recommendation, Assessment, Development, and Evaluation; JOA, Japanese Orthopedic Association; LDH, Lumbar disc herniation; LOS, Length of stay; MD, Mean difference; ODI, Oswestry disability index; RCTs, randomized controlled trials; RoB-2, Risk of Bias assessment tool, version 2; ROBINS-I, Risk of Bias In Non-Randomized Studies of Interventions; RR, Risk ratio; SMD, Standardized mean difference; VAS, Visual analog scale.
References
1
AtkinsD.BestD.BrissP. A.EcclesM.Falck-YtterY.FlottorpS.et al (2004). Grading quality of evidence and strength of recommendations. BMJ Clin. Research ed.328 (7454), 1490. 10.1136/bmj.328.7454.1490
2
BabingtonP.ZookJ.StrengeK. B.NunleyP.BeristainJ.StoneM.et al (2025). Beyond pain relief: preventing recurrence and preserving function after lumbar discectomy. Int. Journal Spine Surgery19 (S3), S54–S58. 10.14444/8803
3
BaileyA.AraghiA.BlumenthalS.HuffmonG. V. (2013). Prospective, multicenter, randomized, controlled study of anular repair in lumbar discectomy: two-year follow-up. Spine38 (14), 1161–1169. 10.1097/BRS.0b013e31828b2e2f
4
BatemanA. H.BalkovecC.AkensM. K.ChanA. H.HarrisonR. D.OakdenW.et al (2016). Closure of the annulus fibrosus of the intervertebral disc using a novel suture application device-in vivo porcine and ex vivo biomechanical evaluation. Spine Journal Official Journal North Am. Spine Soc.16 (7), 889–895. 10.1016/j.spinee.2016.03.005
5
BhandutiaA.YangM.LiuQ.GaoY.LiuJ.LiuS.et al (2025). Real-world treatment patterns and management gaps of lumbar disc herniation in the United States. North Am. Spine Soc. Journal23, 100757. 10.1016/j.xnsj.2025.100757
6
BoumaG. J.ArdeshiriA.MillerL. E.Van de KelftE.BostelmannR.KlassenP. D.et al (2019). Clinical performance of a bone-anchored annular closure device in older adults. Clin. Interventions Aging14, 1085–1094. 10.2147/CIA.S208098
7
CaiX. N.ChenL. X.ZhongQ.ZhaoC. K.LuoY. J.PanT. F.et al (2013). Discectomy to the late efficacy for lumbar disc herniation in the annulus fibrosus incision closed or open. Sichuan Med. J.34 (9), 1350–1352.
8
CarrageeE. J.HanM. Y.SuenP. W.KimD. (2003). Clinical outcomes after lumbar discectomy for sciatica: the effects of fragment type and anular competence. J. Bone Joint Surgery. Am. Volume85 (1), 102–108. 10.2106/00004623-200301000-00016
9
CastroA. L.GonçalvesR. M. (2025). Trends and considerations in annulus fibrosus in vitro model design. Acta Biomater.195, 42–51. 10.1016/j.actbio.2025.01.060
10
ChenT. (2020). Effect of MED combined fibre ring suture on postoperative pain and recurrence in patients with lumbar disc herniation. Mod. Med. Health Res.4 (03), 187–190.
11
ChenW.HuS. L.ZhuL.XieW.YanH.GaoX. W.et al (2019). Clinical study of lumbar intervertebral Discs Annulus suture, and effects of which on inflammation factor concentrations in blood and drainage fluid. Chin. J. ofTrauma Disabil. Med.27 (5), 3–6.
12
ChenX. D.WanT.YangH. J.LiangP. Z.YangX. J.ShuG. (2023). Influence of self-developed annulus fibrosus on imaging and biomechanics of pig lumbar spine. Chin. J. Bone Jt. Inj.38 (09), 936–940.
13
ChenW. N.YuZ. X.WangH. H.ShiM.WangC.ZhanH. S. (2024). Treatment of lumbar disc herniation by percutaneous endoscopic combined with annulus fibrosus suture. J. Clin. Orthop.27 (05), 626–630.
14
DalalS.AraghiK.MaiE.MaayanO.ShafiK.ShahiP.et al (2025). Annular closure device reduces symptomatic reherniation rates: results of a meta-analysis. HSS Journal The Musculoskeletal Journal Hosp. Special Surg.21 (1), 55–64. 10.1177/15563316231215796
15
DesaiS. U.SrinivasanS. S.KumbarS. G.MossI. L. (2024). Hydrogel-Based strategies for intervertebral disc regeneration: advances, challenges and clinical prospects. Gels Basel, Switz.10 (1), 62. 10.3390/gels10010062
16
DingY. F.LiuS. P.SongK.ZhangH.LiangQ. D. (2022). Analysis of the efficacy of intervertebral foraminoscopic nucleus pulposus removal combined with fibre ring suture in the treatment of lumbar disc herniation. J. Pract. Orthop.28 (05), 436–441.
17
DuS.CuiZ.PengS.WuJ.XuJ.MoW.et al (2025). Clinical efficacy of exercise therapy for lumbar disc herniation: a systematic review and meta-analysis of randomized controlled trials. Front. Medicine12, 1531637. 10.3389/fmed.2025.1531637
18
FengC.HuZ.ZhaoM.LengC.LiG.YangF.et al (2025). Region-specific mitophagy in nucleus pulposus, annulus fibrosus, and cartilage endplate of intervertebral disc degeneration: mechanisms and therapeutic strategies. Front. Pharmacology16, 1579507. 10.3389/fphar.2025.1579507
19
FuH. D.JiangH. S.LiZ.LiuG. J. (2020). The short-term effect of waveflex in the treatment of lumbar disc herniation in young adults. J. Clin. Exp. Med.19 (06), 634–638.
20
FuS.LvR.WangZ.WangF.HuangX.WangL.et al (2024). Clinical efficacy of single-channel percutaneous endoscopic nucleotomy with annulus fibrosus suturing for lumbar disc herniation: a retrospective study. Medicine103 (43), e40298. 10.1097/MD.0000000000040298
21
GaoJ. W.LiangW. Z. (2025). Effect of whether annulus fibrous is sutured on efficacy of unilateral biportal endoscopy surgery for treatment of lumbar disc herniation. Chin. J. Bone Jt. Inj.40 (03), 262–265.
22
GuoY.YunX.ZouC. W.LuY.XingG.ZhangX. W.et al (2017). Early treatment response of finite lumbar discectomy combined with annulus fibrosus suture for lumbar intervertebral disc herniation. J. Spinal Surg.15 (06), 326–330.
23
GuoX.LuZ.XiaoW.HuangH.WuJ.ZouF.et al (2025). Exploring the causes of intervertebral disc Annulus Fibrosus impairment. Cell. Molecular Bioengineering18 (2), 109–121. 10.1007/s12195-025-00844-3
24
GuyattG.OxmanA. D.AklE. A.KunzR.VistG.BrozekJ.et al (2011). GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J. Clinical Epidemiology64 (4), 383–394. 10.1016/j.jclinepi.2010.04.026
25
HeX. L.LiC. J.WangX. Y.LiP.XuZ. W. (2018). Nucleus pulposus removal combined with annulus fibrosus repair for lumbar disc herniation under Quadrant channel. Chin. Remedies and Clin.18 (02), 227–229.
26
HeB.DongM.ZhangQ.BuJ.XuL.HuangS.et al (2024). A suture technique combining annulus fibrosis with posterior longitudinal ligament for lumbar disc herniation under endoscopy. J. Orthopaedics65, 24–30. 10.1016/j.jor.2024.11.015
27
HeW.QianS. J.TangJ. (2025). Percutaneous intervertebral foramenoscopic technique combined with fibre ring suturing for the treatment of lumbar disc herniation in adolescents. Zhejiang J. Trauma Surg.30 (02), 322–324.
28
HuY. N. (2018). Effect of minimally invasive passage of nucleus pulposus combined with fibrous ring repair in the treatment of protrusion of lumbar intervertebral disc. J. Cervicodynia Lumbodynia39 (03), 309–312.
29
HuX. Y.ChenK. W. (2024). Analysis of the therapeutic effect of fiber ring suture repair after PTED on elderly lumbar disc herniation. Med. Sci. J. Central South China52 (02), 282–285.
30
HuangX.HuangL.ShiL.XuL.CaoC.WuH.et al (2025). Evaluation of the efficacy of a novel lumbar exoskeleton with multiple interventions for patients with lumbar disc herniation: a multicenter randomized controlled trial of non-inferiority. Front. Bioengineering Biotechnology12, 1520610. 10.3389/fbioe.2024.1520610
31
HwangJ. S.LeeS. H.JeongD.JangJ. W.ChoY. E.LeeD. G.et al (2025). Far-Lateral transforaminal unilateral biportal Endoscopic Lumbar Discectomy for upper Lumbar disc herniations. Neurospine22 (1), 14–27. 10.14245/ns.2550058.029
32
JiangX.LiF.PanH. S.HuoX. T.XiaoQ. B.YangG. X. (2017). Clinical effectiveness of annulus repair after discectomy under Mast Quadrant system for lumbar disc herniation. Chin. J. Tissue Eng. Res.21 (24), 3912–3917.
33
JiaoS. J.LiY.WeiZ. Y. (2021). Comparison of different surgical procedures in the treatment of patients with lumbar disc herniation. J. Community Med.19 (11), 676–679.
34
JinH.LopezA. M.RomeroF. G.HoangR.RameshA.BowH. C. (2025a). A Systematic Review of Treatment Guidelines for lumbar disc herniation. Neurospine22 (2), 389–402. 10.14245/ns.2550398.199
35
JinH.HoangR.CowmanA. W.SongJ.HoangT.ChoS. K.et al (2025b). Adverse events associated with the Barricaid annular closure device: an analysis of the FDA MAUDE Database. J. Craniovertebral Junction and Spine16 (4), 438–443. 10.4103/jcvjs.jcvjs_143_25
36
JungJ. M.LeeS. U.HyunS. J.KimK. J.JahngT. A.OhC. W.et al (2020). Trends in incidence and treatment of herniated lumbar disc in Republic of Korea: a nationwide database Study. J. Korean Neurosurg. Soc.63 (1), 108–118. 10.3340/jkns.2019.0075
37
JungB.HanJ.SongJ.NganA.EssigD.VermaR. (2023). Interventional therapy and surgical management of Lumbar disc herniation in spine surgery: a narrative review. Orthop. Reviews15, 88931. 10.52965/001c.88931
38
KienzlerJ. C.ReyS.WetzelO.AtassiH.BäblerS.BurnF.et al (2021a). Incidence and clinical impact of vertebral endplate changes after limited lumbar microdiscectomy and implantation of a bone-anchored annular closure device. BMC Surgery21 (1), 19. 10.1186/s12893-020-01011-3
39
KienzlerJ. C.HeideckeV.AssakerR.FandinoJ.BarthM. (2021b). Intraoperative findings, complications, and short-term results after lumbar microdiscectomy with or without implantation of annular closure device. Acta Neurochirurgica163 (2), 545–559. 10.1007/s00701-020-04612-2
40
KongF. G.LuanJ. Y.PanQ. P.XieY. Y.ZhuH. M.LiZ. S. (2025). A classification of disc annulus fibrosus injury and its guiding role in the repair and reconstruction of annulus fibrosus in patients with lumbar disc herniation. Chin. J. Spine Spinal Cord35 (10), 1027–1038.
41
KurzbuchA. R.TuleascaC.FournierJ. Y. (2022). Lumbar discectomy with annulus fibrosus closure: a retrospective series of 53 consecutive patients. Neuro-Chirurgie68 (4), 393–397. 10.1016/j.neuchi.2021.12.009
42
LeeJ. S.LeeS. B.KangK. Y.OhS. H.ChaeD. S. (2025a). Review of recent treatment strategies for Lumbar disc herniation (LDH) focusing on nonsurgical and regenerative therapies. J. Clinical Medicine14 (4), 1196. 10.3390/jcm14041196
43
LeeC. C.LinR. M.JuanW. S.ChuangH. Y.LinH. L.ChengC. H.et al (2025b). Comparing clinical outcomes of microdiscectomy, interspinous device implantation, and full-endoscopic discectomy for simple lumbar disc herniation. J. Clinical Medicine14 (6), 1925. 10.3390/jcm14061925
44
LiQ. (2019). Clinical observation of MED combined with fibrous ring suture technique in the treatment of lumbar disc herniation. J. Cervicodynia Lumbodynia40 (02), 191–193.
45
LiL. M. (2024). Effect of intervertebral foramen endoscopic lumbar disc nucleus pulposus Removal combined with fiber ring suture repair on Lumbar Disc herniation. Med. Innovation China21 (6), 32–36.
46
LiB.DuJ. (2024). The effect of AUSS fiber ring repair technology on the function of the lumbar spine in patients with lumbar Disc herniation. Int. J. Clin. Res.8 (10).
47
LiJ.WangX. (2025). Clinical observation of percutaneous transforaminal endoscopic discectomy for lumbar disc herniation and analysis of influencing factors for recurrence. Am. Journal Translational Research17 (3), 2283–2292. 10.62347/AAIH8947
48
LiC. J.LiQ. C.WangX. Y.LiuZ. Z.YangY. (2014). Microendoscopic discectomy associated with annulus repair: comparison of early functional recovery of the lumbar spine. Chin. J. Tissue Eng. Res.18 (46), 7386–7390.
49
LiX.HuZ.CuiJ.HanY.PanJ.YangM.et al (2016a). “Percutaneous endoscopic lumbar discectomy for recurrent lumbar disc herniation,” Int. Journal Surgery, 27. 8–16. 10.1016/j.ijsu.2016.01.034
50
LiJ.MaC.LiY. M.WangZ. H.ZhaoM.FengJ.et al (2016b). Comparison of results between fenestration discectomy associated with annulus repair and fenestration discectomy for lumbar disc herniation in the adolescents. Natl. Med. J. China96 (32), 2573–2577. 10.3760/cma.j.issn.0376-2491.2016.32.012
51
LiX. T.SongH. G.LiuM. C. (2017). Fenestration discectomy associated with annulus repair in treatment of lumbar disc herniation. Chin. J. Pract. Med.44 (17), 66–69.
52
LiJ.YuanX.LiF.WangF.LiY.WangE.et al (2021a). A novel full endoscopic annular repair technique combined with autologous conditioned plasma intradiscal injection: a new safe serial therapeutic model for the treatment of lumbar disc herniation. Ann. Palliative Medicine10 (1), 292–301. 10.21037/apm-20-2257
53
LiC.BaiQ.LaiY.TianJ.LiJ.SunX.et al (2021b). Advances and prospects in biomaterials for intervertebral disk regeneration. Front. Bioengineering Biotechnology9, 766087. 10.3389/fbioe.2021.766087
54
LiZ. P.LiuL. L.TanJ. H.LiuH.XuZ.LiX. L.et al (2022). Factors associated with early recurrent lumbar disc herniation after percutaneous transforaminal endoscopic discectomy. Orthop. J. China30 (19), 1732–1737.
55
LiH.DengW.WeiF.ZhangL.ChenF. (2023). Factors related to the postoperative recurrence of lumbar disc herniation treated by percutaneous transforaminal endoscopy: a meta-analysis. Front. Surgery9, 1049779. 10.3389/fsurg.2022.1049779
56
LiangL. B.ZhuY.LiY.LuW. L.FanX. H.LiG. L.et al (2023). Effectiveness of unilateral biportal endoscopic discectomy and annulus fibrosus suture in the treatment of lumbar disc herniation. Chin. J. Exp. Surg.40 (5), 978–980.
57
LiuY. J. (2018). Modified discoscopic disc removal with fibre annulus suturing. J. Hunan Univ. Chin. Med.38 (0), 483.
58
LiuB.ZhangT. W.LiuY. Q.WuR.LiJ. J.TanY. C.et al (2023). Comparison of endoscopic discectomies with or without repair of annulus fibrosus defect. Orthop. J. China31 (17), 1567–1572.
59
LiuB.ZhangT. W.LiuY. Q.LiJ. J.JiangZ. W.WangL. J.et al (2024). Clinical efficacy of Annulus Fibrosus repair affter discectomy under endoscopic treatment of Lumbar Disc herniation. Chin. J. Traditional Med. Traumatology and Orthop.32 (01), 76–79.
60
LiuS.ZhangX.XiongY.HeH. (2025). Minimally invasive surgery for lumbar disc herniation: a meta-analysis of efficacy and safety. Int. Journal Surgery Lond. Engl.111 (8), 5623–5636. 10.1097/JS9.0000000000002434
61
LorioM.KimC.AraghiA.InzanaJ.YueJ. J. (2020). International Society for the advancement of spine surgery Policy 2019-Surgical treatment of Lumbar disc herniation with radiculopathy. Int. Journal Spine Surgery14 (1), 1–17. 10.14444/7001
62
LvT. C. (2017). Efficacy of posterior discoscopic fibrous annulus repair in the treatment of patients with lumbar disc herniation. J. Clin. Med. Pract.21 (13), 130–131.
63
MaoL.ShenZ.ZhuW.WangK.FanP.WuX.et al (2025). Comparison of the efficacy of microendoscopic discectomy and percutaneous endoscopic lumbar discectomy for treating adolescent lumbar disc herniation. Sci. Reports15 (1), 10185. 10.1038/s41598-025-94635-5
64
McClureJ. J.JentoftM. E.SandhuS. S.ChenS. G.Abode-IyamahK. O. (2024). Bone-anchored annular closure device leading to histiocytic-inflammation-induced neuropathy with resolution after removal: a case report. Eur. Spine Journal Official Publication Eur. Spine Soc. Eur.33 (7), 2840–2845. 10.1007/s00586-023-07910-2
65
MillerL. E.McGirtM. J.GarfinS. R.BonoC. M. (2018). Association of annular defect width after lumbar discectomy with risk of symptom recurrence and reoperation: systematic review and meta-analysis of comparative studies. Spine43 (5), E308–E315. 10.1097/BRS.0000000000002501
66
MillerL. E.AllenR. T.DuhonB.RadcliffK. E. (2020). Expert review with meta-analysis of randomized and nonrandomized controlled studies of Barricaid annular closure in patients at high risk for lumbar disc reherniation. Expert Review Medical Devices17 (5), 461–469. 10.1080/17434440.2020.1745061
67
NingQ.LiM.LiY. X.HuangL. (2023). Research progress of lumbar intervertebral disc annulus fibrosus repair. Chin. J. Spine Spinal Cord33 (08), 753–759.
68
OnginiE. D.AbdullahM.EngilesJ. B.OrozcoB. S.MoehlA.PeredoA.et al (2025). Annulus Fibrosus repair via interpenetration of a non-woven scaffold supports tissue integration and prevents Re-Herniation. JOR Spine8 (1), e70045. 10.1002/jsp2.70045
69
PageM. J.ShamseerL.TriccoA. C. (2018). Registration of systematic reviews in PROSPERO: 30,000 records and counting. Syst. Rev.7 (1), 32. 10.1186/s13643-018-0699-4
70
PageM. J.MoherD.BossuytP. M.BoutronI.HoffmannT. C.MulrowC. D.et al (2021). PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ372, n160. 10.1136/bmj.n160
71
ParkS. M.SongK. S.HamD. W.KangM. S.YouK. H.ParkC. K.et al (2025). Comparing the efficacy and safety of biportal endoscopic discectomy with microscopic discectomy for lumbar herniated intervertebral disc: a multicentre, prospective, assessor-blinded, randomized controlled trial. Bone and Joint Journal107 (5), 529–539. 10.1302/0301-620X.107B5.BJJ-2024-1560.R1
72
PengY. X.ZhangY.YangY.WangF.YuB. (2024). Clinical effect of full endoscopic lumbar annulus fibrosus suture. J. Orthopaedic Surgery Research19 (1), 261. 10.1186/s13018-024-04725-9
73
RenC.QinR.LiY.WangP. (2020). Microendoscopic discectomy combined with annular suture versus percutaneous transforaminal endoscopic discectomy for Lumbar disc herniation: a prospective observational Study. Pain Physician23 (6), E713–E721.
74
SamirA.AshrafA.MosaidE. M.ElhoisI. S.AbdullahA.ElzanatyF. A.et al (2025). “Risk factors and reoperation rate in revision lumbar disc herniation surgery: a systematic review and meta-analysis of 1,031,348 patients,”. Glob. Spine Journal. 10.1177/21925682251392171
75
ShiH. F.ZhangN. N.HuaH. N. (2024). Clinical study of percutaneous transforaminal endoscopic discectomy (PTED) combined with annulus fibrosus repair in treatment of lumbar disc herniation (LDH). J. Xinjiang Med. Univ.47 (09), 1220–1225.
76
SongT. Q.LiJ.LiY. M.WangT.MaC. (2018). Microendoscopic discectomy combined with annulus fibrosus repair versus percutaneous transforaminal endoscopic discectomy for lumbar disc herniation in youngsters. Orthop. J. China26 (23), 2135–2140.
77
SongK.LiuS. P.ZhangH.ZhangW. W.DingY. F.WuD. P.et al (2020). Percutaneous endoscopic interlaminar approach for nucleus pulposus removal combined with fibre ring repair treatment of L5/S1 disc herniation. Chin. J. Bone Jt. Inj.35 (05), 494–496.
78
SongJ. G.CuiY. K.YinZ. Y.ChuJ. S. (2023). Clinical observation of the treatment of lumbar disc herniation with fibrous annulus suture under endoscope. Chin. J. Spine Spinal Cord33 (01), 45–50.
79
SterneJ. A.HernánM. A.ReevesB. C.SavovićJ.BerkmanN. D.ViswanathanM.et al (2016). ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ Clin. Research ed.355, i4919. 10.1136/bmj.i4919
80
SterneJ. A. C.SavovićJ.PageM. J.ElbersR. G.BlencoweN. S.BoutronI.et al (2019). RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ Clin. Research ed.366, l4898. 10.1136/bmj.l4898
81
SunY. H.MaX. X.QuC. P.LiL.ZhangH.WangC.et al (2024). Application and clinical efficacy of percutaneous endoscopic interlaminar discectomy combined with annulus repair in young patients with lumbar disc herniation. J. Clin. Orthop. Res.9 (1), 25–30.
82
TakahashiT.SatoH.TakahashiY.WatanabeK.BannoT.SakakiK.et al (2025). Cost-effectiveness of intradiscal injection with condoliase versus microendoscopic discectomy for lumbar disc herniation: a retrospective multicenter study. Sci. Reports15 (1), 43913. 10.1038/s41598-025-27802-3
83
TangS. Y.XuJ. (2022). Effectiveness analysis of MED surgery combined with microscopic fibrous annulus repair in the treatment of lumbar disc herniation. J. Cervicodynia Lumbodynia43 (05), 722–724.
84
TangG.LiY.LiuY.LinL.WangJ.WangX.et al (2025). Robustly injectable Tetra-PEG hydrogel sealants for annulus fibrosus repair. Adv. Healthcare Materials14 (3), e2403163. 10.1002/adhm.202403163
85
TavakoliJ.DiwanA. D.TipperJ. L. (2020). Advanced strategies for the regeneration of lumbar Disc Annulus fibrosus. Int. Journal Molecular Sciences21 (14), 4889. 10.3390/ijms21144889
86
ThoméC.KuršumovicA.KlassenP. D.BoumaG. J.BostelmannR.MartensF.et al (2021). Effectiveness of an annular closure device to prevent recurrent lumbar disc herniation: a secondary analysis with 5 years of Follow-up. JAMA Network Open4 (12), e2136809. 10.1001/jamanetworkopen.2021.36809
87
TianC. X.YiB. K.LongM. X.ChengL. R. (2023). Application effect of disposable annulus fibrosus stapler in intervertebral discectomy and annulus fibrosus repair of Lumbar Disc herniation. Chin. Community Dr.39 (8), 19–21.
88
WangY. P.YinH. P.WuY. M.LiS. W.DuZ. C.BaiM.et al (2018). Suturing and bonding for repair of annulus fibrosus defects in goats. Chin. J. Tissue Eng. Res.22 (26), 4156–4161.
89
WangX.ChenH.HanJ. H.ZhuQ. S. (2022a). Current application of Barricaid annular closure device in lumbar discectomy. Orthop. J. China30 (22), 2068–2073.
90
WangZ.HuangS.XuL.BuJ.LiuG.WangH.et al (2022b). A retrospective study of the mid-term efficacy of full-endoscopic annulus fibrosus suture following lumbar discectomy. Front. Surgery9, 1011746. 10.3389/fsurg.2022.1011746
91
WangY.HeX.ChenS.WengY.LiuZ.PanQ.et al (2024). Annulus Fibrosus repair for lumbar disc herniation: a meta-analysis of clinical outcomes from controlled studies. Glob. Spine Journal14 (1), 306–321. 10.1177/21925682231169963
92
WangZ.WangL.LiS.ChenX.ChenB.LouZ.et al (2025a). “Crosslinking stabilization strategy: a novel approach to cartilage-like repair of annulus fibrosus (AF) defects,” Mater. Today, 31. 10.1016/j.mtbio.2025.101625
93
WangF.LiJ.LiJ.SunK.ZhangB.WangD.et al (2025b). Bone anchoring annular suture technique for repairing annular defects at vertebral body edge following lumbar discectomy. Sci. Reports15 (1), 5047. 10.1038/s41598-025-89179-7
94
WuF.LiZ. G.XuB.ZhouD. B. (2023). Clinical efficacy of percutaneous transforaminal endoscopic discectomy combined with Annulus fibrosus suture on adolescent Lumbar Disc herniation. Orthopaedics14 (06), 501–505.
95
XiJ.WangX.LiX.WuC.ZhangT.LuQ. (2024). Analysis of the clinical efficacy of visualization of percutaneous endoscopic lumbar discectomy combined with annulus fibrosus suture in lumbar disc herniation. Neurosurg. Review47 (1), 54. 10.1007/s10143-023-02276-x
96
XiaoJ. J. (2021). The effect of nucleus pulposus removal combined with fibre ring suturing on ODI and VAS scores in patients with lumbar disc herniation. Pract. Clin. J. Integr. Traditional Chin. West. Med.21 (03), 125–126.
97
XinL.LiX.YangY.ChenP.LiY.LiuJ.et al (2025). Polyphenol and metal ion-reinforced supermolecular hydrogels incorporating nanofiber drug and peptide for annulus fibrosus regeneration. Theranostics15 (12), 5756–5771. 10.7150/thno.106913
98
XuB. H.LuY. S.ShiH. C.CaoB. S.KouG. (2018). Clinical observation of annulus fibrosus suture in MED. Chin. J. Trauma Disabil. Med.26 (14), 34–36.
99
XuB. S.ZhangH.YuanQ. M.ZhangY.HuY. C.ZhangK. H.et al (2022). Repair of defects after lumbar discectomy with autologous bone marrow mesenchymal stem cells and annular suture. Chin. J. Orthop.42 (11), 685–695.
100
XuB.HuangZ. L.ZhangL.ShenX. F.ChenH.LuB. J.et al (2023). Prevalence rate of lumbar disc herniation in the Chinese population: a meta-analysis. J. Traditional Chin. Orthop. Traumatology35 (09), 17–23.
101
YaoD. Y.ZhengJ.ChenY.LuY. Y. (2022). Wiltse approach discectomy under quadrant channel and annulus fibrosus repair for treatment of single-segment lumbar disc herniation. J. Spinal Surg.20 (01), 16–21.
102
YeF.LyuF. J.WangH.ZhengZ. (2022). The involvement of immune system in intervertebral disc herniation and degeneration. JOR Spine5 (1), e1196. 10.1002/jsp2.1196
103
YiJ. F.ChenH. S.LiuY. J.BaiR. F. (2019). Clinical efficacy of modified MED with fibrous annular suture in the treatment of lumbar disc herniation. J. Prev. Med. Chin. People’s Liberation Army37 (12), 103–104.
104
YingY.CaiK.CaiX.ZhangK.QiuR.JiangG.et al (2023). Recent advances in the repair of degenerative intervertebral disc for preclinical applications. Front. Bioengineering Biotechnology11, 1259731. 10.3389/fbioe.2023.1259731
105
YuL. T.ChenY. J.TanL.LiuT.LiP.MaG. B. (2017). The application of MED combined with an annulus fibrosus suture device in the treatment of Lumbar Disc herniation. Health Way0 (6), 29.
106
YuY.WangY. T.XieY. Z.FengC. Z.FangX. H. (2024). Unilateral biportal endoscopy discectomy combined with annulus fibrosus suture for treatment of lumbar disc herniation. J. Clin. Orthop.27 (02), 166–170.
107
YuanP.ShiX.WeiX.WangZ.MuJ.ZhangH. (2023). Development process and clinical application of collagenase chemonucleolysis in the treatment of lumbar disc herniation: a narrative review in China. Postgrad. Medical Journal99 (1172), 529–534. 10.1136/postgradmedj-2021-141208
108
ZhangY. F. (2017). An investigation of the application of fibrous annulus repair techniques in posterior discoscopic surgery. J. Cervicodynia Lumbodynia38 (06), 604–605.
109
ZhangA. J. (2019). Clinical application of fiber suture in endoscopic treatment of lumbar disc herniation. J. Cervicodynia Lumbodynia40 (03), 350–353.
110
ZhangZ. C.JiangX. W.DaiW. X.WuD. H.MaC.WangZ. H.et al (2015). Waveflex elastic fixation and discectomy annulus in repair and reconstruction of spinal stability in patients with lumbar disc herniation. Chin. J. Tissue Eng. Res.19 (44), 7131–7136.
111
ZhangL.WangJ. C.FengX. M.WangY. X.YangJ. D.TaoY. P.et al (2017a). The early clinical effects of lumbar discectomy associated with annulus repair in the treatment of lumbar disc herniation. J. Chin. Physician19 (10), 1492–1495.
112
ZhangG. G.ChengH.YuF.ShenM. C.LiZ. (2017b). Comparison of the effect between fenestration discectomy associated with annulus repair and fenestration discectomy in the treatment of lubar intervertebral disc protrusion in underage patients. J. Xinxiang Med. Univ.34 (05), 423–425.
113
ZhangL.WangJ. C.LiuZ. J.FengX. M. (2021a). Analysis of the curative effect of discectomy under Quadrant expandable channel associated with annulus repair for the treatment of adolescent lumbar disc herniation. J. Chin. Physician23 (4), 544–547552.
114
ZhangS.HuB.LiuW.WangP.LvX.ChenS.et al (2021b). The role of structure and function changes of sensory nervous system in intervertebral disc-related low back pain. Osteoarthr. Cartilage29 (1), 17–27. 10.1016/j.joca.2020.09.002
115
ZhangA. S.XuA.AnsariK.HardackerK.AndersonG.AlsoofD.et al (2023a). Lumbar disc herniation: diagnosis and management. Am. Journal Medicine136 (7), 645–651. 10.1016/j.amjmed.2023.03.024
116
ZhangA.ChengZ.ChenY.ShiP.GanW.ZhangY. (2023b). Emerging tissue engineering strategies for annulus fibrosus therapy. Acta Biomater.167, 1–15. 10.1016/j.actbio.2023.06.012
117
ZhangQ.HeB.LiuZ.WangZ.BuJ.DongM.et al (2025a). Full-endoscopic posterior longitudinal ligament coverage suturing for lumbar disc herniation with annular defects. J. Orthopaedics63, 165–170. 10.1016/j.jor.2025.03.048
118
ZhangS.MaX.YaoY.PanH.ZouL. (2025b). Global, regional, and national burdens of low back pain in women of childbearing age from 1990 to 2021: an analysis based on the global burden of disease study 2021. BMC Public Health25 (1), 515. 10.1186/s12889-025-21659-x
119
ZhangH.ZhangC.LiL.HuM. L.ZhaoJ. N.ZhengZ.et al (2025c). Developments and clinical experiences in collagenase chemonucleolysis for lumbar disc herniation: a narrative review. Front. Medicine11, 1522568. 10.3389/fmed.2024.1522568
120
ZhaoR.LiN.LuoX. (2024a). A commentary on 'percutaneous endoscopic lumbar discectomy for recurrent lumbar disc herniation. Int. Journal Surgery Lond. Engl.110 (5), 3134–3136. 10.1097/JS9.0000000000001205
121
ZhaoY. F.TianB. W.MaQ. S.ZhangM. (2024b). Study on the clinical effect of percutaneous transforaminal endoscopic discectomy combined with annulus fibrosus repair in the treatment of single-segment lumbar disc herniation in young and middle-aged patients. Pak. Journal Medical Sciences40 (3Part-II), 427–432. 10.12669/pjms.40.3.3419
122
ZhaoY. G.YeX. Y.ChengS. (2024c). Construction of a nomogram model for predicting recurrence after percutaneous transforaminal endoscopic discectomy in patients with lumbar disc herniation. J. Chin. Practical Diagnosis Therapy38 (10), 1034–1039.
123
ZhongR. W.ChenJ. Y.LiuZ. L. (2024). Risk factors for postoperative numbness syndrome secondary to lumbar disc herniation based on propensity score matching. J. Clin. Med. Pract.28 (21), 105–110.
124
ZhouD.LiuH.ZhengZ.WuD. (2023a). Design principles in mechanically adaptable biomaterials for repairing annulus fibrosus rupture: a review. Bioact. Materials31, 422–439. 10.1016/j.bioactmat.2023.08.012
125
ZhouM.TheologisA. A.O'ConnellG. D. (2023b). Understanding the etiopathogenesis of lumbar intervertebral disc herniation: from clinical evidence to basic scientific research. JOR Spine7 (1), e1289. 10.1002/jsp2.1289
126
ZhouW.BanguraM. L.GongQ.ZhangR.ZengT.FeiQ.et al (2025). Comparative outcomes of unilateral biportal endoscopic lumbar intervertebral discectomy with and without annulus fibrosus suture in lumbar disc herniation: a retrospective analysis. Front. Surgery12, 1521892. 10.3389/fsurg.2025.1521892
127
ZhuR. S.RenY. M.YuanJ. J.CuiZ. J.WanJ.FanB. Y.et al (2016). Does local lavage influence functional recovery during lumber discectomy of disc herniation? one year's systematic follow-up of 410 patients. Medicine95 (42), e5022. 10.1097/MD.0000000000005022
128
ZhuG. H.GuoC. L.ChenQ. (2017a). Efficacy analysis of minimally invasive small-incision nucleus pulposus removal combined with fibrous ring repair in the treatment of lumbar disc herniation. J. Cervicodynia Lumbodynia38 (05), 432–434.
129
ZhuZ. Y.LiQ. C.YangY.ChenZ. X.LiuZ. Z.HuangB.et al (2017b). Microendoscopic lumbar discectomy combined with annulus suture in lumbar disc herniation. Chin. J. Spine Spinal Cord27 (03), 213–219.
130
ZhuH.DaY. F.YaoM. Y.DongY. Z.SongX. Y.HuangZ.et al (2024). Progress in preclinical research of biological scaffold materials in the treatment of intervertebral disc degeneration. Chin. J. Spine Spinal Cord34 (07), 780–784.
131
ZhuY.HuangP. P.LiC. X.HuX. Y. (2025a). Progress in the application of fibrosus annulus repair technique in the treatment of lumbar disc herniation. Orthopaedics16 (06), 566–572.
132
ZhuL.WuR.LiuJ.ZhengT. Y.LengZ. (2025b). Analysis of risk factors for recurrence after percutaneous lumbar discectomy for lumbar disc herniation. Chin. J. Bone Jt.14 (03), 222–227.
Summary
Keywords
annulus fibrosus suture, lumbar disc herniation, meta-analysis, surger, systematic review
Citation
Ouyang W, Guo G, Sun Y, Jiang H, Chen L and Yang S (2026) The efficacy and safety of annulus fibrosus suture as adjuvant therapy for lumbar disc herniation: a systematic review and meta-analysis. Front. Bioeng. Biotechnol. 13:1741738. doi: 10.3389/fbioe.2025.1741738
Received
07 November 2025
Revised
23 December 2025
Accepted
29 December 2025
Published
27 January 2026
Volume
13 - 2025
Edited by
Corrado Ciatti, Guglielmo da Saliceto Hospital, Italy
Updates
Copyright
© 2026 Ouyang, Guo, Sun, Jiang, Chen and Yang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Long Chen, 946196756@qq.com; Shaofeng Yang, shaofengy666@163.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.